TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-111458	Formation of apoptosome	0.000952554262919421	-6.95636348364181	3	2	0.0108108108108108	185	10293	842,54205	CASP9,CYCS
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.00310050287239988	-5.77619096374359	5	2	0.0108108108108108	185	10293	842,54205	CASP9,CYCS
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.00310050287239988	-5.77619096374359	5	2	0.0108108108108108	185	10293	842,54205	CASP9,CYCS
R-HSA-947581	Molybdenum cofactor biosynthesis	0.0045958562650429	-5.38260019340919	6	2	0.0108108108108108	185	10293	4338,55034	MOCS2,MOCOS
R-HSA-111471	Apoptotic factor-mediated response	0.00635835853160875	-5.05798502745606	7	2	0.0108108108108108	185	10293	842,54205	CASP9,CYCS
R-HSA-3247509	Chromatin modifying enzymes	0.011963378116093	-4.42590511916313	279	11	0.0594594594594595	185	10293	8518,6597,51742,554313,22992,54014,29072,55257,23338,26610,8370	IKBKAP,SMARCA4,ARID4B,HIST2H4B,KDM2A,BRWD1,SETD2,MRGBP,JADE2,ELP4,HIST2H4A
R-HSA-4839726	Chromatin organization	0.011963378116093	-4.42590511916313	279	11	0.0594594594594595	185	10293	554313,8518,6597,51742,54014,22992,29072,55257,8370,26610,23338	HIST2H4B,IKBKAP,SMARCA4,ARID4B,BRWD1,KDM2A,SETD2,MRGBP,HIST2H4A,ELP4,JADE2
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.0137183641191724	-4.28901989708972	79	5	0.027027027027027	185	10293	5683,126374,55662,7428,112399	PSMA2,WTIP,HIF1AN,VHL,EGLN3
R-HSA-2262749	Cellular response to hypoxia	0.0137183641191724	-4.28901989708972	79	5	0.027027027027027	185	10293	112399,7428,126374,55662,5683	EGLN3,VHL,WTIP,HIF1AN,PSMA2
R-HSA-112315	Transmission across Chemical Synapses	0.0164360280529498	-4.10827952116334	217	9	0.0486486486486487	185	10293	3763,8500,23229,7915,6854,818,112,785,6532	KCNJ6,PPFIA1,ARHGEF9,ALDH5A1,SYN2,CAMK2G,ADCY6,CACNB4,SLC6A4
R-HSA-5578775	Ion homeostasis	0.0179489943164149	-4.02022119255809	56	4	0.0216216216216216	185	10293	444,818,53826,486	ASPH,CAMK2G,FXYD6,FXYD2
R-HSA-2022857	Keratan sulfate degradation	0.0188380333494164	-3.97187740225627	12	2	0.0108108108108108	185	10293	2720,5549	GLB1,PRELP
R-HSA-168638	NOD1/2 Signaling Pathway	0.0193303389615067	-3.94607945040055	32	3	0.0162162162162162	185	10293	7334,841,842	UBE2N,CASP8,CASP9
R-HSA-936837	Ion transport by P-type ATPases	0.0201712427544455	-3.90349731491083	58	4	0.0216216216216216	185	10293	53826,538,818,486	FXYD6,ATP7A,CAMK2G,FXYD2
R-HSA-193648	NRAGE signals death through JNK	0.0225558963539673	-3.79175876810152	60	4	0.0216216216216216	185	10293	55701,23263,102465803,23229	ARHGEF40,MCF2L,MIR7706,ARHGEF9
R-HSA-428157	Sphingolipid metabolism	0.022877615651897	-3.77759632891937	90	5	0.027027027027027	185	10293	91012,253782,412,2720,204219	CERS5,CERS6,STS,GLB1,CERS3
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.0253707084707073	-3.67415998023042	14	2	0.0108108108108108	185	10293	8615,5862	USO1,RAB2A
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.035356024434422	-3.34228647868677	69	4	0.0216216216216216	185	10293	7334,64421,8370,554313	UBE2N,DCLRE1C,HIST2H4A,HIST2H4B
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.035356024434422	-3.34228647868677	69	4	0.0216216216216216	185	10293	5683,126374,7428,112399	PSMA2,WTIP,VHL,EGLN3
R-HSA-77042	Formation of editosomes by ADAR proteins	0.035625432502118	-3.33469550005669	2	1	0.00540540540540541	185	10293	104	ADARB1
R-HSA-916853	Degradation of GABA	0.035625432502118	-3.33469550005669	2	1	0.00540540540540541	185	10293	7915	ALDH5A1
R-HSA-75064	mRNA Editing: A to I Conversion	0.035625432502118	-3.33469550005669	2	1	0.00540540540540541	185	10293	104	ADARB1
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.035625432502118	-3.33469550005669	2	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-75102	C6 deamination of adenosine	0.035625432502118	-3.33469550005669	2	1	0.00540540540540541	185	10293	104	ADARB1
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.035625432502118	-3.33469550005669	2	1	0.00540540540540541	185	10293	54205	CYCS
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.0407074502320564	-3.20134415090095	18	2	0.0108108108108108	185	10293	6854,8500	SYN2,PPFIA1
R-HSA-3214847	HATs acetylate histones	0.044105797700804	-3.12116403803197	143	6	0.0324324324324324	185	10293	55257,26610,8370,23338,554313,8518	MRGBP,ELP4,HIST2H4A,JADE2,HIST2H4B,IKBKAP
R-HSA-194840	Rho GTPase cycle	0.044105797700804	-3.12116403803197	143	6	0.0324324324324324	185	10293	394,23229,102465803,9754,55701,23263	ARHGAP5,ARHGEF9,MIR7706,STARD8,ARHGEF40,MCF2L
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.0441859063372561	-3.11934940189356	44	3	0.0162162162162162	185	10293	841,842,54205	CASP8,CASP9,CYCS
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.0441859063372561	-3.11934940189356	44	3	0.0162162162162162	185	10293	204219,253782,91012	CERS3,CERS6,CERS5
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.0449697738549906	-3.10176470700935	19	2	0.0108108108108108	185	10293	8556,119504	CDC14A,ANAPC16
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.0477041942775631	-3.04273595460625	76	4	0.0216216216216216	185	10293	102465803,23229,23263,55701	MIR7706,ARHGEF9,MCF2L,ARHGEF40
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.0529618716236452	-2.93818302765221	3	1	0.00540540540540541	185	10293	6532	SLC6A4
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.0529618716236452	-2.93818302765221	3	1	0.00540540540540541	185	10293	55662	HIF1AN
R-HSA-1483255	PI Metabolism	0.0536400934600338	-2.9254584782131	79	4	0.0216216216216216	185	10293	126282,84725,8396,3635	TNFAIP8L1,PLEKHA8,PIP4K2B,INPP5D
R-HSA-1221632	Meiotic synapsis	0.0536400934600338	-2.9254584782131	79	4	0.0216216216216216	185	10293	23224,8370,23345,554313	SYNE2,HIST2H4A,SYNE1,HIST2H4B
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	0.0539574529616736	-2.91955945109776	21	2	0.0108108108108108	185	10293	85456,4849	TNKS1BP1,CNOT3
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.054813367488644	-2.90382118250028	48	3	0.0162162162162162	185	10293	7334,842,841	UBE2N,CASP9,CASP8
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.0586691227411022	-2.83584170858325	22	2	0.0108108108108108	185	10293	10299,9695	MARCH6,EDEM1
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.0605435982892315	-2.80439154059668	50	3	0.0162162162162162	185	10293	8396,84725,3635	PIP4K2B,PLEKHA8,INPP5D
R-HSA-112310	Neurotransmitter Release Cycle	0.063509868659393	-2.75655997319973	51	3	0.0162162162162162	185	10293	7915,6854,8500	ALDH5A1,SYN2,PPFIA1
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.0635172116482602	-2.75644436023189	23	2	0.0108108108108108	185	10293	6854,8500	SYN2,PPFIA1
R-HSA-5365859	RA biosynthesis pathway	0.0635172116482602	-2.75644436023189	23	2	0.0108108108108108	185	10293	112724,195814	RDH13,SDR16C5
R-HSA-2262752	Cellular responses to stress	0.064652899300604	-2.73872232866613	453	13	0.0702702702702703	185	10293	112399,8370,818,538,119504,55662,54205,7428,128866,554313,23112,126374,5683	EGLN3,HIST2H4A,CAMK2G,ATP7A,ANAPC16,HIF1AN,CYCS,VHL,CHMP4B,HIST2H4B,TNRC6B,WTIP,PSMA2
R-HSA-3214842	HDMs demethylate histones	0.0665423493115009	-2.70991670225973	52	3	0.0162162162162162	185	10293	554313,8370,22992	HIST2H4B,HIST2H4A,KDM2A
R-HSA-75153	Apoptotic execution  phase	0.0696400811557157	-2.66441499872218	53	3	0.0162162162162162	185	10293	1677,100506658,841	DFFB,OCLN,CASP8
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.0699883102763805	-2.65942704692988	4	1	0.00540540540540541	185	10293	22987	SV2C
R-HSA-3000497	Scavenging by Class H Receptors	0.0699883102763805	-2.65942704692988	4	1	0.00540540540540541	185	10293	6678	SPARC
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	0.0699883102763805	-2.65942704692988	4	1	0.00540540540540541	185	10293	538	ATP7A
R-HSA-8847453	Synthesis of PIPs in the nucleus	0.0699883102763805	-2.65942704692988	4	1	0.00540540540540541	185	10293	8396	PIP4K2B
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.0699883102763805	-2.65942704692988	4	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-1369007	Mitochondrial ABC transporters	0.0699883102763805	-2.65942704692988	4	1	0.00540540540540541	185	10293	22	ABCB7
R-HSA-429947	Deadenylation of mRNA	0.0735973665236741	-2.6091460348158	25	2	0.0108108108108108	185	10293	4849,85456	CNOT3,TNKS1BP1
R-HSA-416482	G alpha (12/13) signalling events	0.0737258338619207	-2.6074020139084	88	4	0.0216216216216216	185	10293	23263,55701,23229,102465803	MCF2L,ARHGEF40,ARHGEF9,MIR7706
R-HSA-397014	Muscle contraction	0.0750572067625176	-2.58950469936341	204	7	0.0378378378378378	185	10293	486,785,859,444,818,53826,7135	FXYD2,CACNB4,CAV3,ASPH,CAMK2G,FXYD6,TNNI1
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.0760273197491136	-2.57666253290673	55	3	0.0162162162162162	185	10293	6721,6319,51128	SREBF2,SCD,SAR1B
R-HSA-977443	GABA receptor activation	0.0793147721282916	-2.53433088612223	56	3	0.0162162162162162	185	10293	23229,3763,112	ARHGEF9,KCNJ6,ADCY6
R-HSA-429914	Deadenylation-dependent mRNA decay	0.082663370871085	-2.49297869077497	57	3	0.0162162162162162	185	10293	4849,9652,85456	CNOT3,TTC37,TNKS1BP1
R-HSA-983712	Ion channel transport	0.0829111376807291	-2.48998587507227	209	7	0.0378378378378378	185	10293	486,196527,23229,538,818,53826,444	FXYD2,ANO6,ARHGEF9,ATP7A,CAMK2G,FXYD6,ASPH
R-HSA-5687128	MAPK6/MAPK4 signaling	0.0837188915186429	-2.48029062183309	92	4	0.0216216216216216	185	10293	8556,989,23112,5683	CDC14A,SEPT7,TNRC6B,PSMA2
R-HSA-901042	Calnexin/calreticulin cycle	0.0841491559719224	-2.47516438843814	27	2	0.0108108108108108	185	10293	10299,9695	MARCH6,EDEM1
R-HSA-75157	FasL/ CD95L signaling	0.0867102621286362	-2.44518303854798	5	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.0867102621286362	-2.44518303854798	5	1	0.00540540540540541	185	10293	842	CASP9
R-HSA-111463	SMAC binds to IAPs	0.0867102621286362	-2.44518303854798	5	1	0.00540540540540541	185	10293	842	CASP9
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.0867102621286362	-2.44518303854798	5	1	0.00540540540540541	185	10293	22987	SV2C
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.0867102621286362	-2.44518303854798	5	1	0.00540540540540541	185	10293	22987	SV2C
R-HSA-111469	SMAC-mediated apoptotic response	0.0867102621286362	-2.44518303854798	5	1	0.00540540540540541	185	10293	842	CASP9
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.0895874398107697	-2.41254014951086	28	2	0.0108108108108108	185	10293	3635,113026	INPP5D,PLCD3
R-HSA-174800	Chylomicron-mediated lipid transport	0.0895874398107697	-2.41254014951086	28	2	0.0108108108108108	185	10293	51128,26119	SAR1B,LDLRAP1
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.0895874398107697	-2.41254014951086	28	2	0.0108108108108108	185	10293	842,841	CASP9,CASP8
R-HSA-1266695	Interleukin-7 signaling	0.0895874398107697	-2.41254014951086	28	2	0.0108108108108108	185	10293	6597,54014	SMARCA4,BRWD1
R-HSA-109581	Apoptosis	0.0936854075750348	-2.36781283745775	174	6	0.0324324324324324	185	10293	1677,841,842,5683,100506658,54205	DFFB,CASP8,CASP9,PSMA2,OCLN,CYCS
R-HSA-193704	p75 NTR receptor-mediated signalling	0.0970915330334758	-2.33210110590627	97	4	0.0216216216216216	185	10293	23263,55701,102465803,23229	MCF2L,ARHGEF40,MIR7706,ARHGEF9
R-HSA-5357801	Programmed Cell Death	0.0996294134001712	-2.30629784272579	177	6	0.0324324324324324	185	10293	1677,841,5683,842,100506658,54205	DFFB,CASP8,PSMA2,CASP9,OCLN,CYCS
R-HSA-112316	Neuronal System	0.0997415783213287	-2.30517265463275	350	10	0.0540540540540541	185	10293	3763,8500,23229,7915,6854,818,112,3785,785,6532	KCNJ6,PPFIA1,ARHGEF9,ALDH5A1,SYN2,CAMK2G,ADCY6,KCNQ2,CACNB4,SLC6A4
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.102705160912725	-2.27589291099548	99	4	0.0216216216216216	185	10293	7037,11037,1856,26119	TFRC,STON1,DVL2,LDLRAP1
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.103133143302771	-2.27173447208469	6	1	0.00540540540540541	185	10293	27031	NPHP3
R-HSA-1566977	Fibronectin matrix formation	0.103133143302771	-2.27173447208469	6	1	0.00540540540540541	185	10293	1088	CEACAM8
R-HSA-6798163	Choline catabolism	0.103133143302771	-2.27173447208469	6	1	0.00540540540540541	185	10293	23446	SLC44A1
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.103133143302771	-2.27173447208469	6	1	0.00540540540540541	185	10293	1856	DVL2
R-HSA-5660668	CLEC7A/inflammasome pathway	0.103133143302771	-2.27173447208469	6	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-382551	Transmembrane transport of small molecules	0.103221548028491	-2.27087764900441	679	17	0.0918918918918919	185	10293	486,818,538,23229,23315,57818,55356,117247,7037,112,53826,196527,23446,5683,113235,22,444	FXYD2,CAMK2G,ATP7A,ARHGEF9,SLC9A8,G6PC2,SLC22A15,SLC16A10,TFRC,ADCY6,FXYD6,ANO6,SLC44A1,PSMA2,SLC46A1,ABCB7,ASPH
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.10556702602887	-2.24840920998574	100	4	0.0216216216216216	185	10293	9702,4867,91147,10382	CEP57,NPHP1,TMEM67,TUBB4A
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.111365185156269	-2.19494052137271	313	9	0.0486486486486487	185	10293	5683,22888,7428,57630,79791,27246,5071,7334,53339	PSMA2,UBOX5,VHL,SH3RF1,FBXO31,RNF115,PARK2,UBE2N,BTBD1
R-HSA-5576891	Cardiac conduction	0.112687864573123	-2.18313354276595	142	5	0.027027027027027	185	10293	444,53826,818,486,785	ASPH,FXYD6,CAMK2G,FXYD2,CACNB4
R-HSA-5610787	Hedgehog 'off' state	0.114367544972571	-2.16833793807849	103	4	0.0216216216216216	185	10293	51684,112,27152,5683	SUFU,ADCY6,INTU,PSMA2
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.118187629673558	-2.13548183537901	33	2	0.0108108108108108	185	10293	5549,2720	PRELP,GLB1
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	0.119262274098735	-2.12643022705765	7	1	0.00540540540540541	185	10293	5549	PRELP
R-HSA-3656225	Defective CHST6 causes MCDC1	0.119262274098735	-2.12643022705765	7	1	0.00540540540540541	185	10293	5549	PRELP
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	0.119262274098735	-2.12643022705765	7	1	0.00540540540540541	185	10293	5549	PRELP
R-HSA-162791	Attachment of GPI anchor to uPAR	0.119262274098735	-2.12643022705765	7	1	0.00540540540540541	185	10293	80055	PGAP1
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.119262274098735	-2.12643022705765	7	1	0.00540540540540541	185	10293	23112	TNRC6B
R-HSA-75158	TRAIL  signaling	0.119262274098735	-2.12643022705765	7	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-5653656	Vesicle-mediated transport	0.125462718436426	-2.07574662879421	651	16	0.0864864864864865	185	10293	22836,11037,5049,57186,134829,414918,26119,128866,89953,8615,4641,1856,7037,8907,51128,6678	RHOBTB3,STON1,PAFAH1B2,RALGAPA2,CLVS2,DENND6B,LDLRAP1,CHMP4B,KLC4,USO1,MYO1C,DVL2,TFRC,AP1M1,SAR1B,SPARC
R-HSA-5617833	Cilium Assembly	0.132223737759456	-2.02325980823216	192	6	0.0324324324324324	185	10293	27031,9702,200132,10382,91147,4867	NPHP3,CEP57,TCTEX1D1,TUBB4A,TMEM67,NPHP1
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.135102880679123	-2.00171871167393	8	1	0.00540540540540541	185	10293	29780	PARVB
R-HSA-199991	Membrane Trafficking	0.135876695204361	-1.99600745741354	611	15	0.0810810810810811	185	10293	51128,8907,7037,1856,26119,414918,134829,57186,5049,11037,8615,4641,128866,22836,89953	SAR1B,AP1M1,TFRC,DVL2,LDLRAP1,DENND6B,CLVS2,RALGAPA2,PAFAH1B2,STON1,USO1,MYO1C,CHMP4B,RHOBTB3,KLC4
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.136296429486068	-1.99292313661641	36	2	0.0108108108108108	185	10293	10299,9695	MARCH6,EDEM1
R-HSA-432720	Lysosome Vesicle Biogenesis	0.136296429486068	-1.99292313661641	36	2	0.0108108108108108	185	10293	8907,134829	AP1M1,CLVS2
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.138249046042081	-1.97869853884161	375	10	0.0540540540540541	185	10293	7334,53339,51128,5071,27246,57630,79791,7428,5683,22888	UBE2N,BTBD1,SAR1B,PARK2,RNF115,SH3RF1,FBXO31,VHL,PSMA2,UBOX5
R-HSA-1280218	Adaptive Immune System	0.141894510874285	-1.95267137862084	812	19	0.102702702702703	185	10293	3635,5592,842,5071,7428,22888,23112,7334,10718,53339,27246,8396,51128,8907,57630,79791,89953,5683,5133	INPP5D,PRKG1,CASP9,PARK2,VHL,UBOX5,TNRC6B,UBE2N,NRG3,BTBD1,RNF115,PIP4K2B,SAR1B,AP1M1,SH3RF1,FBXO31,KLC4,PSMA2,PDCD1
R-HSA-3214841	PKMTs methylate histone lysines	0.143627038328399	-1.94053535089722	73	3	0.0162162162162162	185	10293	8370,554313,29072	HIST2H4A,HIST2H4B,SETD2
R-HSA-421837	Clathrin derived vesicle budding	0.143627038328399	-1.94053535089722	73	3	0.0162162162162162	185	10293	134829,8907,7037	CLVS2,AP1M1,TFRC
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.143627038328399	-1.94053535089722	73	3	0.0162162162162162	185	10293	7037,134829,8907	TFRC,CLVS2,AP1M1
R-HSA-194315	Signaling by Rho GTPases	0.146724295775524	-1.91919999217083	427	11	0.0594594594594595	185	10293	5217,8370,1856,554313,9754,102465803,394,23229,23263,89953,55701	PFN2,HIST2H4A,DVL2,HIST2H4B,STARD8,MIR7706,ARHGAP5,ARHGEF9,MCF2L,KLC4,ARHGEF40
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.148688315508181	-1.90590300622156	38	2	0.0108108108108108	185	10293	54205,538	CYCS,ATP7A
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.150660096726574	-1.89272899456585	9	1	0.00540540540540541	185	10293	51071	DERA
R-HSA-425986	Sodium/Proton exchangers	0.150660096726574	-1.89272899456585	9	1	0.00540540540540541	185	10293	23315	SLC9A8
R-HSA-2428933	SHC-related events triggered by IGF1R	0.150660096726574	-1.89272899456585	9	1	0.00540540540540541	185	10293	3480	IGF1R
R-HSA-2214320	Anchoring fibril formation	0.150660096726574	-1.89272899456585	9	1	0.00540540540540541	185	10293	3918	LAMC2
R-HSA-1640170	Cell Cycle	0.151934793697433	-1.88430383901057	623	15	0.0810810810810811	185	10293	23224,10382,8556,984,8615,554313,23345,23063,5683,8370,5862,119504,7334,9702,84515	SYNE2,TUBB4A,CDC14A,CDK11B,USO1,HIST2H4B,SYNE1,WAPL,PSMA2,HIST2H4A,RAB2A,ANAPC16,UBE2N,CEP57,MCM8
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.152089401128442	-1.88328676571859	75	3	0.0162162162162162	185	10293	554313,7334,8370	HIST2H4B,UBE2N,HIST2H4A
R-HSA-166520	Signalling by NGF	0.153793501756187	-1.87214447406336	479	12	0.0648648648648649	185	10293	112,818,10718,842,8396,55701,23263,102465803,283455,5683,23229,23112	ADCY6,CAMK2G,NRG3,CASP9,PIP4K2B,ARHGEF40,MCF2L,MIR7706,KSR2,PSMA2,ARHGEF9,TNRC6B
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.1549675191903	-1.86453973763328	39	2	0.0108108108108108	185	10293	100506658,841	OCLN,CASP8
R-HSA-5693606	DNA Double Strand Break Response	0.156379204150312	-1.85547142550251	76	3	0.0162162162162162	185	10293	554313,8370,7334	HIST2H4B,HIST2H4A,UBE2N
R-HSA-69620	Cell Cycle Checkpoints	0.158979479679052	-1.838980143713	203	6	0.0324324324324324	185	10293	554313,84515,5683,8370,119504,7334	HIST2H4B,MCM8,PSMA2,HIST2H4A,ANAPC16,UBE2N
R-HSA-977444	GABA B receptor activation	0.161296953014977	-1.82450818420313	40	2	0.0108108108108108	185	10293	3763,112	KCNJ6,ADCY6
R-HSA-991365	Activation of GABAB receptors	0.161296953014977	-1.82450818420313	40	2	0.0108108108108108	185	10293	3763,112	KCNJ6,ADCY6
R-HSA-1250342	PI3K events in ERBB4 signaling	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	8396	PIP4K2B
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	6532	SLC6A4
R-HSA-201688	WNT mediated activation of DVL	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	1856	DVL2
R-HSA-170660	Adenylate cyclase activating pathway	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-168799	Neurotoxicity of clostridium toxins	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	22987	SV2C
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	84515	MCM8
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	8907	AP1M1
R-HSA-2562578	TRIF-mediated programmed cell death	0.165938965079116	-1.79613523848284	10	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-1483257	Phospholipid metabolism	0.169256941343683	-1.77633735566038	207	6	0.0324324324324324	185	10293	3635,137964,126282,23446,84725,8396	INPP5D,GPAT4,TNFAIP8L1,SLC44A1,PLEKHA8,PIP4K2B
R-HSA-3214858	RMTs methylate histone arginines	0.169468523324386	-1.77508807250755	79	3	0.0162162162162162	185	10293	8370,554313,6597	HIST2H4A,HIST2H4B,SMARCA4
R-HSA-1500620	Meiosis	0.173261486121864	-1.75295334514804	121	4	0.0216216216216216	185	10293	23345,554313,23224,8370	SYNE1,HIST2H4B,SYNE2,HIST2H4A
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.174091413719381	-1.74817475152078	42	2	0.0108108108108108	185	10293	6721,6319	SREBF2,SCD
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.176802808940515	-1.7327202412322	122	4	0.0216216216216216	185	10293	1582,55034,113235,4338	CYP8B1,MOCOS,SLC46A1,MOCS2
R-HSA-5362517	Signaling by Retinoic Acid	0.18054918675212	-1.71175203554951	43	2	0.0108108108108108	185	10293	112724,195814	RDH13,SDR16C5
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-75072	mRNA Editing	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	104	ADARB1
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	100506658	OCLN
R-HSA-68689	CDC6 association with the ORC:origin complex	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	84515	MCM8
R-HSA-2470946	Cohesin Loading onto Chromatin	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	23063	WAPL
R-HSA-8851805	MET activates RAS signaling	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	57610	RANBP10
R-HSA-549127	Organic cation transport	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	55356	SLC22A15
R-HSA-3371378	Regulation by c-FLIP	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-937039	IRAK1 recruits IKK complex	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-69416	Dimerization of procaspase-8	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-5218900	CASP8 activity is inhibited	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-446107	Type I hemidesmosome assembly	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	3918	LAMC2
R-HSA-5625970	RHO GTPases activate KTN1	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	89953	KLC4
R-HSA-418889	Ligand-independent caspase activation via DCC	0.180944439302374	-1.70956526002002	11	1	0.00540540540540541	185	10293	842	CASP9
R-HSA-75109	Triglyceride Biosynthesis	0.182862399786932	-1.69902132270224	82	3	0.0162162162162162	185	10293	137964,79993,6319	GPAT4,ELOVL7,SCD
R-HSA-380287	Centrosome maturation	0.182862399786932	-1.69902132270224	82	3	0.0162162162162162	185	10293	10382,9702,984	TUBB4A,CEP57,CDK11B
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.182862399786932	-1.69902132270224	82	3	0.0162162162162162	185	10293	10382,9702,984	TUBB4A,CEP57,CDK11B
R-HSA-917937	Iron uptake and transport	0.187042676296425	-1.67641847267584	44	2	0.0108108108108108	185	10293	113235,7037	SLC46A1,TFRC
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.187389133276305	-1.67456789764511	83	3	0.0162162162162162	185	10293	2821,23112,54205	GPI,TNRC6B,CYCS
R-HSA-1257604	PIP3 activates AKT signaling	0.187572502093606	-1.67358983047971	125	4	0.0216216216216216	185	10293	842,23112,8396,10718	CASP9,TNRC6B,PIP4K2B,NRG3
R-HSA-69481	G2/M Checkpoints	0.194393532714826	-1.63787065543704	171	5	0.027027027027027	185	10293	554313,84515,5683,8370,7334	HIST2H4B,MCM8,PSMA2,HIST2H4A,UBE2N
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.195681385301638	-1.63126752764459	12	1	0.00540540540540541	185	10293	23063	WAPL
R-HSA-5689877	Josephin domain DUBs	0.195681385301638	-1.63126752764459	12	1	0.00540540540540541	185	10293	5071	PARK2
R-HSA-176974	Unwinding of DNA	0.195681385301638	-1.63126752764459	12	1	0.00540540540540541	185	10293	84515	MCM8
R-HSA-211979	Eicosanoids	0.195681385301638	-1.63126752764459	12	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	0.195681385301638	-1.63126752764459	12	1	0.00540540540540541	185	10293	8738	CRADD
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.195681385301638	-1.63126752764459	12	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.195681385301638	-1.63126752764459	12	1	0.00540540540540541	185	10293	158	ADSL
R-HSA-210990	PECAM1 interactions	0.195681385301638	-1.63126752764459	12	1	0.00540540540540541	185	10293	3635	INPP5D
R-HSA-180292	GAB1 signalosome	0.19854875458568	-1.61672059397212	128	4	0.0216216216216216	185	10293	842,8396,23112,10718	CASP9,PIP4K2B,TNRC6B,NRG3
R-HSA-198203	PI3K/AKT activation	0.19854875458568	-1.61672059397212	128	4	0.0216216216216216	185	10293	10718,842,23112,8396	NRG3,CASP9,TNRC6B,PIP4K2B
R-HSA-1660662	Glycosphingolipid metabolism	0.200123531005679	-1.60882044807606	46	2	0.0108108108108108	185	10293	412,2720	STS,GLB1
R-HSA-5576892	Phase 0 - rapid depolarisation	0.206704525219082	-1.57646491984377	47	2	0.0108108108108108	185	10293	818,785	CAMK2G,CACNB4
R-HSA-1483249	Inositol phosphate metabolism	0.206704525219082	-1.57646491984377	47	2	0.0108108108108108	185	10293	3635,113026	INPP5D,PLCD3
R-HSA-556833	Metabolism of lipids and lipoproteins	0.209343888698092	-1.56377697873628	813	18	0.0972972972972973	185	10293	204219,137964,8396,51128,253782,6721,23446,3635,26119,412,79993,6319,1582,2720,200879,84725,126282,91012	CERS3,GPAT4,PIP4K2B,SAR1B,CERS6,SREBF2,SLC44A1,INPP5D,LDLRAP1,STS,ELOVL7,SCD,CYP8B1,GLB1,LIPH,PLEKHA8,TNFAIP8L1,CERS5
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.209716028180298	-1.56200091013587	131	4	0.0216216216216216	185	10293	8396,23112,842,10718	PIP4K2B,TNRC6B,CASP9,NRG3
R-HSA-140342	Apoptosis induced DNA fragmentation	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	1677	DFFB
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	842	CASP9
R-HSA-1663150	The activation of arylsulfatases	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	412	STS
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	22	ABCB7
R-HSA-977441	GABA A receptor activation	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	23229	ARHGEF9
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	785	CACNB4
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-211227	Activation of DNA fragmentation factor	0.210154582825717	-1.5599119103659	13	1	0.00540540540540541	185	10293	1677	DFFB
R-HSA-453276	Regulation of mitotic cell cycle	0.215119764272542	-1.53656036281731	89	3	0.0162162162162162	185	10293	8556,119504,5683	CDC14A,ANAPC16,PSMA2
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.215119764272542	-1.53656036281731	89	3	0.0162162162162162	185	10293	119504,8556,5683	ANAPC16,CDC14A,PSMA2
R-HSA-69278	Cell Cycle, Mitotic	0.218077215742502	-1.52290607825361	516	12	0.0648648648648649	185	10293	554313,23063,5683,10382,8556,984,8615,84515,8370,5862,119504,9702	HIST2H4B,WAPL,PSMA2,TUBB4A,CDC14A,CDK11B,USO1,MCM8,HIST2H4A,RAB2A,ANAPC16,CEP57
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	0.219932489548243	-1.51443464541249	49	2	0.0108108108108108	185	10293	85456,4849	TNKS1BP1,CNOT3
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.224368726993375	-1.49446447782011	14	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.224368726993375	-1.49446447782011	14	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-5675482	Regulation of necroptotic cell death	0.224368726993375	-1.49446447782011	14	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.224553097730207	-1.49364308426317	91	3	0.0162162162162162	185	10293	8370,6597,554313	HIST2H4A,SMARCA4,HIST2H4B
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.229300318158069	-1.47272270160041	92	3	0.0162162162162162	185	10293	4045,80055,93183	LSAMP,PGAP1,PIGM
R-HSA-8856828	Clathrin-mediated endocytosis	0.232561376340154	-1.45860110453371	137	4	0.0216216216216216	185	10293	26119,1856,11037,7037	LDLRAP1,DVL2,STON1,TFRC
R-HSA-171306	Packaging Of Telomere Ends	0.233229359667796	-1.45573293334039	51	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	0.234066453226592	-1.45215021579361	93	3	0.0162162162162162	185	10293	554313,8370,4641	HIST2H4B,HIST2H4A,MYO1C
R-HSA-1474290	Collagen formation	0.234066453226592	-1.45215021579361	93	3	0.0162162162162162	185	10293	10491,1290,3918	CRTAP,COL5A2,LAMC2
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.238328429846736	-1.43410559923753	15	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.238328429846736	-1.43410559923753	15	1	0.00540540540540541	185	10293	1856	DVL2
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.238328429846736	-1.43410559923753	15	1	0.00540540540540541	185	10293	23063	WAPL
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.238328429846736	-1.43410559923753	15	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.238328429846736	-1.43410559923753	15	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.238328429846736	-1.43410559923753	15	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.238328429846736	-1.43410559923753	15	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-3214815	HDACs deacetylate histones	0.238850426632243	-1.43191775295457	94	3	0.0162162162162162	185	10293	8370,554313,51742	HIST2H4A,HIST2H4B,ARID4B
R-HSA-69473	G2/M DNA damage checkpoint	0.243651174145437	-1.41201769072029	95	3	0.0162162162162162	185	10293	7334,8370,554313	UBE2N,HIST2H4A,HIST2H4B
R-HSA-5358351	Signaling by Hedgehog	0.244208439250368	-1.40973315913786	140	4	0.0216216216216216	185	10293	5683,27152,112,51684	PSMA2,INTU,ADCY6,SUFU
R-HSA-68875	Mitotic Prophase	0.248120235753068	-1.39384182872021	141	4	0.0216216216216216	185	10293	8370,5862,8615,554313	HIST2H4A,RAB2A,USO1,HIST2H4B
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-392517	Rap1 signalling	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	5592	PRKG1
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	498	ATP5A1
R-HSA-549132	Organic cation/anion/zwitterion transport	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	55356	SLC22A15
R-HSA-1963642	PI3K events in ERBB2 signaling	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-1170546	Prolactin receptor signaling	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	2690	GHR
R-HSA-163615	PKA activation	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	93183	PIGM
R-HSA-446353	Cell-extracellular matrix interactions	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	29780	PARVB
R-HSA-5218859	Regulated Necrosis	0.252038221676965	-1.37817452965066	16	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-5693607	Processing of DNA double-strand break ends	0.258143604989611	-1.3542392404227	98	3	0.0162162162162162	185	10293	7334,8370,554313	UBE2N,HIST2H4A,HIST2H4B
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.259945010981719	-1.34728516655925	55	2	0.0108108108108108	185	10293	6319,79993	SCD,ELOVL7
R-HSA-195721	Signaling by Wnt	0.262992714366923	-1.33562894921499	338	8	0.0432432432432432	185	10293	8370,5592,1856,56998,23112,554313,5683,6597	HIST2H4A,PRKG1,DVL2,CTNNBIP1,TNRC6B,HIST2H4B,PSMA2,SMARCA4
R-HSA-201681	TCF dependent signaling in response to WNT	0.263146108959321	-1.33504585368984	240	6	0.0324324324324324	185	10293	1856,8370,5683,6597,56998,554313	DVL2,HIST2H4A,PSMA2,SMARCA4,CTNNBIP1,HIST2H4B
R-HSA-140534	Ligand-dependent caspase activation	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	9652	TTC37
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	8500	PPFIA1
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	5261	PHKG2
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-164378	PKA activation in glucagon signalling	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-192456	Digestion of dietary lipid	0.265502552615809	-1.3261308239742	17	1	0.00540540540540541	185	10293	200879	LIPH
R-HSA-202424	Downstream TCR signaling	0.267870150092968	-1.31725293046488	100	3	0.0162162162162162	185	10293	3635,7334,5683	INPP5D,UBE2N,PSMA2
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.26787471965653	-1.31723587173479	146	4	0.0216216216216216	185	10293	23229,3763,112,818	ARHGEF9,KCNJ6,ADCY6,CAMK2G
R-HSA-1852241	Organelle biogenesis and maintenance	0.268113880419442	-1.31634346178895	340	8	0.0432432432432432	185	10293	10382,63931,4867,200132,54205,27031,91147,9702	TUBB4A,MRPS14,NPHP1,TCTEX1D1,CYCS,NPHP3,TMEM67,CEP57
R-HSA-5683057	MAPK family signaling cascades	0.272164825532325	-1.30134741999381	292	7	0.0378378378378378	185	10293	5683,283455,23112,989,818,8556,10718	PSMA2,KSR2,TNRC6B,SEPT7,CAMK2G,CDC14A,NRG3
R-HSA-977225	Amyloid fiber formation	0.272749899228406	-1.29920002373408	101	3	0.0162162162162162	185	10293	5071,554313,8370	PARK2,HIST2H4B,HIST2H4A
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.273324897966957	-1.29709408896466	57	2	0.0108108108108108	185	10293	8907,7037	AP1M1,TFRC
R-HSA-418457	cGMP effects	0.278725793926516	-1.27752679791022	18	1	0.00540540540540541	185	10293	5592	PRKG1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.278725793926516	-1.27752679791022	18	1	0.00540540540540541	185	10293	8500	PPFIA1
R-HSA-196757	Metabolism of folate and pterines	0.278725793926516	-1.27752679791022	18	1	0.00540540540540541	185	10293	113235	SLC46A1
R-HSA-197264	Nicotinamide salvaging	0.278725793926516	-1.27752679791022	18	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.282537483959987	-1.2639440506137	103	3	0.0162162162162162	185	10293	7334,5683,841	UBE2N,PSMA2,CASP8
R-HSA-2132295	MHC class II antigen presentation	0.282537483959987	-1.2639440506137	103	3	0.0162162162162162	185	10293	8907,51128,89953	AP1M1,SAR1B,KLC4
R-HSA-71387	Metabolism of carbohydrates	0.286227740556513	-1.25096748938532	297	7	0.0378378378378378	185	10293	51071,57818,5549,2720,5261,55790,2821	DERA,G6PC2,PRELP,GLB1,PHKG2,CSGALNACT1,GPI
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.287533015694652	-1.24641758813923	199	5	0.027027027027027	185	10293	10718,842,5683,8396,23112	NRG3,CASP9,PSMA2,PIP4K2B,TNRC6B
R-HSA-212165	Epigenetic regulation of gene expression	0.287904342937335	-1.24512699659645	151	4	0.0216216216216216	185	10293	4641,8370,51742,554313	MYO1C,HIST2H4A,ARID4B,HIST2H4B
R-HSA-3858494	Beta-catenin independent WNT signaling	0.287904342937335	-1.24512699659645	151	4	0.0216216216216216	185	10293	5683,23112,1856,5592	PSMA2,TNRC6B,DVL2,PRKG1
R-HSA-176412	Phosphorylation of the APC/C	0.291712239481473	-1.23198744384757	19	1	0.00540540540540541	185	10293	119504	ANAPC16
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.291712239481473	-1.23198744384757	19	1	0.00540540540540541	185	10293	7915	ALDH5A1
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.291712239481473	-1.23198744384757	19	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-416700	Other semaphorin interactions	0.291712239481473	-1.23198744384757	19	1	0.00540540540540541	185	10293	80031	SEMA6D
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.291712239481473	-1.23198744384757	19	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.293372676815274	-1.2263115436654	60	2	0.0108108108108108	185	10293	3918,1290	LAMC2,COL5A2
R-HSA-212436	Generic Transcription Pathway	0.293497429067966	-1.22588639931635	866	18	0.0972972972972973	185	10293	8396,2821,146540,10520,54205,284443,163049,4849,27300,85456,169841,23439,8738,3172,23112,84671,7652,54811	PIP4K2B,GPI,ZNF785,ZNF211,CYCS,ZNF493,ZNF791,CNOT3,ZNF544,TNKS1BP1,ZNF169,ATP1B4,CRADD,HNF4A,TNRC6B,ZNF347,ZNF99,ZNF562
R-HSA-913531	Interferon Signaling	0.294518933554762	-1.22241198744851	201	5	0.027027027027027	185	10293	3454,7334,818,55128,693215	IFNAR1,UBE2N,CAMK2G,TRIM68,MIR630
R-HSA-6802952	Signaling by BRAF and RAF fusions	0.30004133437897	-1.20383503255367	61	2	0.0108108108108108	185	10293	283455,23164	KSR2,MPRIP
R-HSA-4641258	Degradation of DVL	0.30004133437897	-1.20383503255367	61	2	0.0108108108108108	185	10293	5683,1856	PSMA2,DVL2
R-HSA-4086398	Ca2+ pathway	0.30004133437897	-1.20383503255367	61	2	0.0108108108108108	185	10293	5592,23112	PRKG1,TNRC6B
R-HSA-427413	NoRC negatively regulates rRNA expression	0.302198616197704	-1.19667080824828	107	3	0.0162162162162162	185	10293	8370,51742,554313	HIST2H4A,ARID4B,HIST2H4B
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.304466107079347	-1.18919550482742	20	1	0.00540540540540541	185	10293	119504	ANAPC16
R-HSA-8874081	MET activates PTK2 signaling	0.304466107079347	-1.18919550482742	20	1	0.00540540540540541	185	10293	3918	LAMC2
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.304466107079347	-1.18919550482742	20	1	0.00540540540540541	185	10293	119504	ANAPC16
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.304466107079347	-1.18919550482742	20	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-186763	Downstream signal transduction	0.304720145065086	-1.18836148075163	354	8	0.0432432432432432	185	10293	818,112,10718,842,8396,5683,283455,23112	CAMK2G,ADCY6,NRG3,CASP9,PIP4K2B,PSMA2,KSR2,TNRC6B
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.30669987902613	-1.18188560229915	62	2	0.0108108108108108	185	10293	84515,5683	MCM8,PSMA2
R-HSA-1268020	Mitochondrial protein import	0.30669987902613	-1.18188560229915	62	2	0.0108108108108108	185	10293	498,79145	ATP5A1,CHCHD7
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.30669987902613	-1.18188560229915	62	2	0.0108108108108108	185	10293	4641,57186	MYO1C,RALGAPA2
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	0.307126475554713	-1.18049564374139	108	3	0.0162162162162162	185	10293	8370,4641,554313	HIST2H4A,MYO1C,HIST2H4B
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.313346527529085	-1.16044558413739	63	2	0.0108108108108108	185	10293	5683,51684	PSMA2,SUFU
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.313346527529085	-1.16044558413739	63	2	0.0108108108108108	185	10293	5683,51684	PSMA2,SUFU
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.313346527529085	-1.16044558413739	63	2	0.0108108108108108	185	10293	51684,5683	SUFU,PSMA2
R-HSA-73728	RNA Polymerase I Promoter Opening	0.313346527529085	-1.16044558413739	63	2	0.0108108108108108	185	10293	554313,8370	HIST2H4B,HIST2H4A
R-HSA-2424491	DAP12 signaling	0.315388063257094	-1.15395145153244	358	8	0.0432432432432432	185	10293	23112,5683,283455,10718,818,112,8396,842	TNRC6B,PSMA2,KSR2,NRG3,CAMK2G,ADCY6,PIP4K2B,CASP9
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.316991110735656	-1.14888154734139	110	3	0.0162162162162162	185	10293	554313,119504,8370	HIST2H4B,ANAPC16,HIST2H4A
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.316991110735656	-1.14888154734139	110	3	0.0162162162162162	185	10293	8370,51742,554313	HIST2H4A,ARID4B,HIST2H4B
R-HSA-210745	Regulation of gene expression in beta cells	0.316991539791658	-1.14888019381539	21	1	0.00540540540540541	185	10293	3172	HNF4A
R-HSA-69618	Mitotic Spindle Checkpoint	0.316991539791658	-1.14888019381539	21	1	0.00540540540540541	185	10293	119504	ANAPC16
R-HSA-2028269	Signaling by Hippo	0.316991539791658	-1.14888019381539	21	1	0.00540540540540541	185	10293	1856	DVL2
R-HSA-2024096	HS-GAG degradation	0.316991539791658	-1.14888019381539	21	1	0.00540540540540541	185	10293	2720	GLB1
R-HSA-68886	M Phase	0.323542157355135	-1.12842585713244	310	7	0.0378378378378378	185	10293	5683,23063,554313,8615,119504,5862,8370	PSMA2,WAPL,HIST2H4B,USO1,ANAPC16,RAB2A,HIST2H4A
R-HSA-5334118	DNA methylation	0.326597334707873	-1.11902725920206	65	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.329292607265635	-1.11080853969805	22	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.329292607265635	-1.11080853969805	22	1	0.00540540540540541	185	10293	55790	CSGALNACT1
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.329292607265635	-1.11080853969805	22	1	0.00540540540540541	185	10293	8907	AP1M1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.333198253121108	-1.09901761143696	66	2	0.0108108108108108	185	10293	119504,5683	ANAPC16,PSMA2
R-HSA-177929	Signaling by EGFR	0.336942060335635	-1.08784429119849	366	8	0.0432432432432432	185	10293	5683,283455,23112,112,818,10718,842,8396	PSMA2,KSR2,TNRC6B,ADCY6,CAMK2G,NRG3,CASP9,PIP4K2B
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.339780791386281	-1.0794546005173	67	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-5205647	Mitophagy	0.341373307075993	-1.0747786583335	23	1	0.00540540540540541	185	10293	5071	PARK2
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.341373307075993	-1.0747786583335	23	1	0.00540540540540541	185	10293	5071	PARK2
R-HSA-389948	PD-1 signaling	0.341373307075993	-1.0747786583335	23	1	0.00540540540540541	185	10293	5133	PDCD1
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.341373307075993	-1.0747786583335	23	1	0.00540540540540541	185	10293	10382	TUBB4A
R-HSA-3371571	HSF1-dependent transactivation	0.341373307075993	-1.0747786583335	23	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.341373307075993	-1.0747786583335	23	1	0.00540540540540541	185	10293	119504	ANAPC16
R-HSA-73923	Lipid digestion, mobilization, and transport	0.341665558211962	-1.07392292034067	115	3	0.0162162162162162	185	10293	51128,200879,26119	SAR1B,LIPH,LDLRAP1
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.352884915736703	-1.04161329294723	69	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-6806834	Signaling by MET	0.352884915736703	-1.04161329294723	69	2	0.0108108108108108	185	10293	3918,57610	LAMC2,RANBP10
R-HSA-4608870	Asymmetric localization of PCP proteins	0.352884915736703	-1.04161329294723	69	2	0.0108108108108108	185	10293	5683,1856	PSMA2,DVL2
R-HSA-5693532	DNA Double-Strand Break Repair	0.353078067630933	-1.0410660917381	167	4	0.0216216216216216	185	10293	7334,8370,64421,554313	UBE2N,HIST2H4A,DCLRE1C,HIST2H4B
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.353237565901712	-1.0406144571829	24	1	0.00540540540540541	185	10293	5592	PRKG1
R-HSA-201451	Signaling by BMP	0.353237565901712	-1.0406144571829	24	1	0.00540540540540541	185	10293	657	BMPR1A
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.353237565901712	-1.0406144571829	24	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-171052	LDL-mediated lipid transport	0.353237565901712	-1.0406144571829	24	1	0.00540540540540541	185	10293	26119	LDLRAP1
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.353237565901712	-1.0406144571829	24	1	0.00540540540540541	185	10293	8500	PPFIA1
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.353237565901712	-1.0406144571829	24	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-156588	Glucuronidation	0.353237565901712	-1.0406144571829	24	1	0.00540540540540541	185	10293	54577	UGT1A7
R-HSA-2172127	DAP12 interactions	0.355992184030196	-1.03284650334248	373	8	0.0432432432432432	185	10293	5683,283455,23112,842,8396,112,818,10718	PSMA2,KSR2,TNRC6B,CASP9,PIP4K2B,ADCY6,CAMK2G,NRG3
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.358725060329927	-1.02519903256892	374	8	0.0432432432432432	185	10293	10718,7334,818,8396,842,23112,283455,5683	NRG3,UBE2N,CAMK2G,PIP4K2B,CASP9,TNRC6B,KSR2,PSMA2
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.3594037396202	-1.02330889951096	70	2	0.0108108108108108	185	10293	119504,5683	ANAPC16,PSMA2
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.3594037396202	-1.02330889951096	70	2	0.0108108108108108	185	10293	51128,8615	SAR1B,USO1
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.3594037396202	-1.02330889951096	70	2	0.0108108108108108	185	10293	10491,1290	CRTAP,COL5A2
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	3763	KCNJ6
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	119504	ANAPC16
R-HSA-1296041	Activation of G protein gated Potassium channels	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	3763	KCNJ6
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	842	CASP9
R-HSA-1296059	G protein gated Potassium channels	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	3763	KCNJ6
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	51128	SAR1B
R-HSA-162588	Budding and maturation of HIV virion	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	128866	CHMP4B
R-HSA-1251985	Nuclear signaling by ERBB4	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-982772	Growth hormone receptor signaling	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	2690	GHR
R-HSA-3000157	Laminin interactions	0.364889240879532	-1.00816142109492	25	1	0.00540540540540541	185	10293	3918	LAMC2
R-HSA-68867	Assembly of the pre-replicative complex	0.365898655793009	-1.00539888066416	71	2	0.0108108108108108	185	10293	84515,5683	MCM8,PSMA2
R-HSA-186797	Signaling by PDGF	0.369679432714723	-0.995119046951915	378	8	0.0432432432432432	185	10293	10718,112,818,8396,842,23112,5683,283455	NRG3,ADCY6,CAMK2G,PIP4K2B,CASP9,TNRC6B,PSMA2,KSR2
R-HSA-202403	TCR signaling	0.371186407588589	-0.991050896228165	121	3	0.0162162162162162	185	10293	7334,3635,5683	UBE2N,INPP5D,PSMA2
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.372368419739959	-0.987871539162338	72	2	0.0108108108108108	185	10293	554313,8370	HIST2H4B,HIST2H4A
R-HSA-774815	Nucleosome assembly	0.372368419739959	-0.987871539162338	72	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.372368419739959	-0.987871539162338	72	2	0.0108108108108108	185	10293	9702,10382	CEP57,TUBB4A
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	0.372368419739959	-0.987871539162338	72	2	0.0108108108108108	185	10293	10382,9702	TUBB4A,CEP57
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.376332120745484	-0.97728322561698	26	1	0.00540540540540541	185	10293	5549	PRELP
R-HSA-975298	Ligand-gated ion channel transport	0.376332120745484	-0.97728322561698	26	1	0.00540540540540541	185	10293	23229	ARHGEF9
R-HSA-912694	Regulation of IFNA signaling	0.376332120745484	-0.97728322561698	26	1	0.00540540540540541	185	10293	3454	IFNAR1
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.376332120745484	-0.97728322561698	26	1	0.00540540540540541	185	10293	10382	TUBB4A
R-HSA-196854	Metabolism of vitamins and cofactors	0.381738272856213	-0.963020054788873	174	4	0.0216216216216216	185	10293	4338,113235,55034,1582	MOCS2,SLC46A1,MOCOS,CYP8B1
R-HSA-212300	PRC2 methylates histones and DNA	0.385227771323316	-0.953920505802025	74	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-69052	Switching of origins to a post-replicative state	0.385227771323316	-0.953920505802025	74	2	0.0108108108108108	185	10293	84515,5683	MCM8,PSMA2
R-HSA-174824	Lipoprotein metabolism	0.385227771323316	-0.953920505802025	74	2	0.0108108108108108	185	10293	26119,51128	LDLRAP1,SAR1B
R-HSA-2299718	Condensation of Prophase Chromosomes	0.385227771323316	-0.953920505802025	74	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-68949	Orc1 removal from chromatin	0.385227771323316	-0.953920505802025	74	2	0.0108108108108108	185	10293	84515,5683	MCM8,PSMA2
R-HSA-1630316	Glycosaminoglycan metabolism	0.390740636159453	-0.939711273731082	125	3	0.0162162162162162	185	10293	5549,2720,55790	PRELP,GLB1,CSGALNACT1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.391615123920636	-0.937475748232334	75	2	0.0108108108108108	185	10293	5683,119504	PSMA2,ANAPC16
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.391615123920636	-0.937475748232334	75	2	0.0108108108108108	185	10293	5683,119504	PSMA2,ANAPC16
R-HSA-6802957	Oncogenic MAPK signaling	0.391615123920636	-0.937475748232334	75	2	0.0108108108108108	185	10293	23164,283455	MPRIP,KSR2
R-HSA-8854518	AURKA Activation by TPX2	0.391615123920636	-0.937475748232334	75	2	0.0108108108108108	185	10293	9702,10382	CEP57,TUBB4A
R-HSA-2559580	Oxidative Stress Induced Senescence	0.39560725977286	-0.927333328105553	126	3	0.0162162162162162	185	10293	8370,554313,23112	HIST2H4A,HIST2H4B,TNRC6B
R-HSA-1169408	ISG15 antiviral mechanism	0.397972851487623	-0.921371488366922	76	2	0.0108108108108108	185	10293	693215,7334	MIR630,UBE2N
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	0.397972851487623	-0.921371488366922	76	2	0.0108108108108108	185	10293	554313,8370	HIST2H4B,HIST2H4A
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.397972851487623	-0.921371488366922	76	2	0.0108108108108108	185	10293	7334,693215	UBE2N,MIR630
R-HSA-69300	Removal of licensing factors from origins	0.397972851487623	-0.921371488366922	76	2	0.0108108108108108	185	10293	84515,5683	MCM8,PSMA2
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.397972851487623	-0.921371488366922	76	2	0.0108108108108108	185	10293	5683,119504	PSMA2,ANAPC16
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-211976	Endogenous sterols	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	128866	CHMP4B
R-HSA-111997	CaM pathway	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	79993	ELOVL7
R-HSA-2022854	Keratan sulfate biosynthesis	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	5549	PRELP
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	5049	PAFAH1B2
R-HSA-111933	Calmodulin induced events	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-437239	Recycling pathway of L1	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	4478	MSN
R-HSA-5576893	Phase 2 - plateau phase	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	785	CACNB4
R-HSA-1483191	Synthesis of PC	0.39860631549291	-0.919781027142031	28	1	0.00540540540540541	185	10293	23446	SLC44A1
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.399930847724535	-0.916463627508407	389	8	0.0432432432432432	185	10293	283455,5683,23112,842,8396,112,818,10718	KSR2,PSMA2,TNRC6B,CASP9,PIP4K2B,ADCY6,CAMK2G,NRG3
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.401358654334187	-0.912899851576891	231	5	0.027027027027027	185	10293	5683,842,23112,8396,10718	PSMA2,CASP9,TNRC6B,PIP4K2B,NRG3
R-HSA-446203	Asparagine N-linked glycosylation	0.405949144626066	-0.901527386767747	285	6	0.0324324324324324	185	10293	10299,8615,79796,2720,51128,9695	MARCH6,USO1,ALG9,GLB1,SAR1B,EDEM1
R-HSA-1433557	Signaling by SCF-KIT	0.408950108555283	-0.894162114352399	339	7	0.0378378378378378	185	10293	10718,818,8396,23112,842,5683,283455	NRG3,CAMK2G,PIP4K2B,TNRC6B,CASP9,PSMA2,KSR2
R-HSA-196807	Nicotinate metabolism	0.409444876783807	-0.892952995778446	29	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.409444876783807	-0.892952995778446	29	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.409444876783807	-0.892952995778446	29	1	0.00540540540540541	185	10293	10382	TUBB4A
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.409444876783807	-0.892952995778446	29	1	0.00540540540540541	185	10293	8907	AP1M1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.409444876783807	-0.892952995778446	29	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.410595480867875	-0.890146780624762	78	2	0.0108108108108108	185	10293	79796,2720	ALG9,GLB1
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.410595480867875	-0.890146780624762	78	2	0.0108108108108108	185	10293	5683,119504	PSMA2,ANAPC16
R-HSA-69304	Regulation of DNA replication	0.416858518726535	-0.875008398382461	79	2	0.0108108108108108	185	10293	5683,84515	PSMA2,MCM8
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.416858518726535	-0.875008398382461	79	2	0.0108108108108108	185	10293	554313,8370	HIST2H4B,HIST2H4A
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.416858518726535	-0.875008398382461	79	2	0.0108108108108108	185	10293	119504,5683	ANAPC16,PSMA2
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.420089138065619	-0.867288356733495	30	1	0.00540540540540541	185	10293	23112	TNRC6B
R-HSA-445095	Interaction between L1 and Ankyrins	0.420089138065619	-0.867288356733495	30	1	0.00540540540540541	185	10293	3785	KCNQ2
R-HSA-917977	Transferrin endocytosis and recycling	0.420089138065619	-0.867288356733495	30	1	0.00540540540540541	185	10293	7037	TFRC
R-HSA-111996	Ca-dependent events	0.420089138065619	-0.867288356733495	30	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-8863795	Downregulation of ERBB2 signaling	0.420089138065619	-0.867288356733495	30	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-69275	G2/M Transition	0.422420601521666	-0.861753775237604	184	4	0.0216216216216216	185	10293	9702,984,10382,5683	CEP57,CDK11B,TUBB4A,PSMA2
R-HSA-69242	S Phase	0.424575752131898	-0.856664838899265	132	3	0.0162162162162162	185	10293	5683,84515,23063	PSMA2,MCM8,WAPL
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.424575752131898	-0.856664838899265	132	3	0.0162162162162162	185	10293	7334,8370,554313	UBE2N,HIST2H4A,HIST2H4B
R-HSA-2871837	FCERI mediated NF-kB activation	0.429283701621955	-0.845637269480568	81	2	0.0108108108108108	185	10293	7334,5683	UBE2N,PSMA2
R-HSA-70326	Glucose metabolism	0.429283701621955	-0.845637269480568	81	2	0.0108108108108108	185	10293	2821,5261	GPI,PHKG2
R-HSA-453274	Mitotic G2-G2/M phases	0.430490114456211	-0.842830918313635	186	4	0.0216216216216216	185	10293	10382,9702,984,5683	TUBB4A,CEP57,CDK11B,PSMA2
R-HSA-5654687	Downstream signaling of activated FGFR1	0.430542563908975	-0.842709089133054	31	1	0.00540540540540541	185	10293	23768	FLRT2
R-HSA-8875878	MET promotes cell motility	0.430542563908975	-0.842709089133054	31	1	0.00540540540540541	185	10293	3918	LAMC2
R-HSA-5339562	Uptake and actions of bacterial toxins	0.430542563908975	-0.842709089133054	31	1	0.00540540540540541	185	10293	22987	SV2C
R-HSA-1296065	Inwardly rectifying K+ channels	0.430542563908975	-0.842709089133054	31	1	0.00540540540540541	185	10293	3763	KCNJ6
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	0.430542563908975	-0.842709089133054	31	1	0.00540540540540541	185	10293	8396	PIP4K2B
R-HSA-352230	Amino acid transport across the plasma membrane	0.430542563908975	-0.842709089133054	31	1	0.00540540540540541	185	10293	117247	SLC16A10
R-HSA-157579	Telomere Maintenance	0.435444234164242	-0.831388541028211	82	2	0.0108108108108108	185	10293	554313,8370	HIST2H4B,HIST2H4A
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	1856	DVL2
R-HSA-69190	DNA strand elongation	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	84515	MCM8
R-HSA-376176	Signaling by Robo receptor	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	5217	PFN2
R-HSA-2559585	Oncogene Induced Senescence	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	23112	TNRC6B
R-HSA-68962	Activation of the pre-replicative complex	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	84515	MCM8
R-HSA-70263	Gluconeogenesis	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	2821	GPI
R-HSA-70171	Glycolysis	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	2821	GPI
R-HSA-399719	Trafficking of AMPA receptors	0.440808557453858	-0.819144607870306	32	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.44156905146118	-0.817420869217054	83	2	0.0108108108108108	185	10293	119504,5683	ANAPC16,PSMA2
R-HSA-168256	Immune System	0.441829550292682	-0.816831104101884	2103	39	0.210810810810811	185	10293	89953,57630,5133,283455,5683,7334,10718,53339,693215,51128,8396,1088,7428,54014,5049,23112,22888,51071,818,2690,4641,79791,6597,196527,112,2821,4985,841,8907,27246,55128,2720,538,3635,3454,5592,54476,842,5071	KLC4,SH3RF1,PDCD1,KSR2,PSMA2,UBE2N,NRG3,BTBD1,MIR630,SAR1B,PIP4K2B,CEACAM8,VHL,BRWD1,PAFAH1B2,TNRC6B,UBOX5,DERA,CAMK2G,GHR,MYO1C,FBXO31,SMARCA4,ANO6,ADCY6,GPI,OPRD1,CASP8,AP1M1,RNF115,TRIM68,GLB1,ATP7A,INPP5D,IFNAR1,PRKG1,RNF216,CASP9,PARK2
R-HSA-202733	Cell surface interactions at the vascular wall	0.443626818117784	-0.812771569702581	136	3	0.0162162162162162	185	10293	3635,1088,5675	INPP5D,CEACAM8,PSG6
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.44765744409479	-0.803726972765602	84	2	0.0108108108108108	185	10293	841,54476	CASP8,RNF216
R-HSA-211000	Gene Silencing by RNA	0.448352163824957	-0.802176275399771	137	3	0.0162162162162162	185	10293	554313,23112,8370	HIST2H4B,TNRC6B,HIST2H4A
R-HSA-5357905	Regulation of TNFR1 signaling	0.450890461447641	-0.79653084825293	33	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-163359	Glucagon signaling in metabolic regulation	0.450890461447641	-0.79653084825293	33	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-4085001	Sialic acid metabolism	0.450890461447641	-0.79653084825293	33	1	0.00540540540540541	185	10293	2720	GLB1
R-HSA-186712	Regulation of beta-cell development	0.450890461447641	-0.79653084825293	33	1	0.00540540540540541	185	10293	3172	HNF4A
R-HSA-5693538	Homology Directed Repair	0.453061579863978	-0.791727224848244	138	3	0.0162162162162162	185	10293	554313,7334,8370	HIST2H4B,UBE2N,HIST2H4A
R-HSA-113510	E2F mediated regulation of DNA replication	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	84515	MCM8
R-HSA-73847	Purine metabolism	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	158	ADSL
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	10382	TUBB4A
R-HSA-1483166	Synthesis of PA	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	137964	GPAT4
R-HSA-5694530	Cargo concentration in the ER	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	51128	SAR1B
R-HSA-390522	Striated Muscle Contraction	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	7135	TNNI1
R-HSA-1489509	DAG and IP3 signaling	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	23439	ATP1B4
R-HSA-192105	Synthesis of bile acids and bile salts	0.460791559360469	-0.774809487128313	34	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.465697523777362	-0.764218946213521	87	2	0.0108108108108108	185	10293	10718,8396	NRG3,PIP4K2B
R-HSA-2559583	Cellular Senescence	0.470346791478836	-0.754285002148332	196	4	0.0216216216216216	185	10293	554313,23112,119504,8370	HIST2H4B,TNRC6B,ANAPC16,HIST2H4A
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	0.470515076413164	-0.753927277083972	35	1	0.00540540540540541	185	10293	283455	KSR2
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.470515076413164	-0.753927277083972	35	1	0.00540540540540541	185	10293	10988	METAP2
R-HSA-68874	M/G1 Transition	0.471633841505221	-0.751552353976547	88	2	0.0108108108108108	185	10293	5683,84515	PSMA2,MCM8
R-HSA-5632684	Hedgehog 'on' state	0.471633841505221	-0.751552353976547	88	2	0.0108108108108108	185	10293	51684,5683	SUFU,PSMA2
R-HSA-69002	DNA Replication Pre-Initiation	0.471633841505221	-0.751552353976547	88	2	0.0108108108108108	185	10293	84515,5683	MCM8,PSMA2
R-HSA-912446	Meiotic recombination	0.471633841505221	-0.751552353976547	88	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-446728	Cell junction organization	0.471633841505221	-0.751552353976547	88	2	0.0108108108108108	185	10293	29780,3918	PARVB,LAMC2
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.480064180606522	-0.733835474421611	36	1	0.00540540540540541	185	10293	54476	RNF216
R-HSA-445355	Smooth Muscle Contraction	0.480064180606522	-0.733835474421611	36	1	0.00540540540540541	185	10293	859	CAV3
R-HSA-2514856	The phototransduction cascade	0.480064180606522	-0.733835474421611	36	1	0.00540540540540541	185	10293	10988	METAP2
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.480064180606522	-0.733835474421611	36	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-167021	PLC-gamma1 signalling	0.480064180606522	-0.733835474421611	36	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.48338764496502	-0.726936369655392	90	2	0.0108108108108108	185	10293	9702,10382	CEP57,TUBB4A
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.48338764496502	-0.726936369655392	90	2	0.0108108108108108	185	10293	10718,842	NRG3,CASP9
R-HSA-2586552	Signaling by Leptin	0.485952100251218	-0.721645219092789	255	5	0.027027027027027	185	10293	283455,5683,3953,818,10718	KSR2,PSMA2,LEPR,CAMK2G,NRG3
R-HSA-73777	RNA Polymerase I Chain Elongation	0.489204151652223	-0.714975388589793	91	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-176187	Activation of ATR in response to replication stress	0.48944198373459	-0.714489345517738	37	1	0.00540540540540541	185	10293	84515	MCM8
R-HSA-438064	Post NMDA receptor activation events	0.48944198373459	-0.714489345517738	37	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-419037	NCAM1 interactions	0.48944198373459	-0.714489345517738	37	1	0.00540540540540541	185	10293	785	CACNB4
R-HSA-5621481	C-type lectin receptors (CLRs)	0.490110992251221	-0.713123398729659	146	3	0.0162162162162162	185	10293	7334,5683,841	UBE2N,PSMA2,CASP8
R-HSA-912526	Interleukin receptor SHC signaling	0.492839124126635	-0.707572478423429	257	5	0.027027027027027	185	10293	10718,818,3635,283455,5683	NRG3,CAMK2G,INPP5D,KSR2,PSMA2
R-HSA-3700989	Transcriptional Regulation by TP53	0.493953501757401	-0.705313892221508	368	7	0.0378378378378378	185	10293	85456,8738,2821,8396,54205,23112,4849	TNKS1BP1,CRADD,GPI,PIP4K2B,CYCS,TNRC6B,CNOT3
R-HSA-5689901	Metalloprotease DUBs	0.498651542344074	-0.695847739099689	38	1	0.00540540540540541	185	10293	10617	STAMBP
R-HSA-5625740	RHO GTPases activate PKNs	0.500714151491675	-0.69171989663107	93	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.506406841158919	-0.680414898845872	94	2	0.0108108108108108	185	10293	8396,10718	PIP4K2B,NRG3
R-HSA-877300	Interferon gamma signaling	0.506406841158919	-0.680414898845872	94	2	0.0108108108108108	185	10293	818,55128	CAMK2G,TRIM68
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	0.507695858744957	-0.677872713955976	39	1	0.00540540540540541	185	10293	283455	KSR2
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	0.507695858744957	-0.677872713955976	39	1	0.00540540540540541	185	10293	283455	KSR2
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.507695858744957	-0.677872713955976	39	1	0.00540540540540541	185	10293	412	STS
R-HSA-5674135	MAP2K and MAPK activation	0.507695858744957	-0.677872713955976	39	1	0.00540540540540541	185	10293	283455	KSR2
R-HSA-451927	Interleukin-2 signaling	0.516672681724318	-0.660345715757655	264	5	0.027027027027027	185	10293	283455,5683,10718,818,3635	KSR2,PSMA2,NRG3,CAMK2G,INPP5D
R-HSA-5620924	Intraflagellar transport	0.525300508690107	-0.643784782642512	41	1	0.00540540540540541	185	10293	200132	TCTEX1D1
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.525300508690107	-0.643784782642512	41	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-4086400	PCP/CE pathway	0.528754079274656	-0.637231833711161	98	2	0.0108108108108108	185	10293	1856,5683	DVL2,PSMA2
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	0.53386658418733	-0.627609313583565	42	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.53386658418733	-0.627609313583565	42	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-983189	Kinesins	0.53386658418733	-0.627609313583565	42	1	0.00540540540540541	185	10293	89953	KLC4
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.534233523046458	-0.626922226537924	99	2	0.0108108108108108	185	10293	841,7334	CASP8,UBE2N
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.534233523046458	-0.626922226537924	99	2	0.0108108108108108	185	10293	7334,841	UBE2N,CASP8
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.534233523046458	-0.626922226537924	99	2	0.0108108108108108	185	10293	841,7334	CASP8,UBE2N
R-HSA-1296071	Potassium Channels	0.53966951024924	-0.61679834484028	100	2	0.0108108108108108	185	10293	3763,3785	KCNJ6,KCNQ2
R-HSA-1236394	Signaling by ERBB4	0.542278903161535	-0.611974828415291	43	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.542278903161535	-0.611974828415291	43	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-75893	TNF signaling	0.542278903161535	-0.611974828415291	43	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.542278903161535	-0.611974828415291	43	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.542278903161535	-0.611974828415291	43	1	0.00540540540540541	185	10293	56998	CTNNBIP1
R-HSA-194068	Bile acid and bile salt metabolism	0.542278903161535	-0.611974828415291	43	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.542278903161535	-0.611974828415291	43	1	0.00540540540540541	185	10293	6678	SPARC
R-HSA-373760	L1CAM interactions	0.545061825619691	-0.606856049248875	101	2	0.0108108108108108	185	10293	3785,4478	KCNQ2,MSN
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.546618158405289	-0.604004785393623	273	5	0.027027027027027	185	10293	818,3635,10718,283455,5683	CAMK2G,INPP5D,NRG3,KSR2,PSMA2
R-HSA-1296072	Voltage gated Potassium channels	0.550540210776135	-0.596855281388655	44	1	0.00540540540540541	185	10293	3785	KCNQ2
R-HSA-69239	Synthesis of DNA	0.555714687233084	-0.587500268897818	103	2	0.0108108108108108	185	10293	84515,5683	MCM8,PSMA2
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.558653203343555	-0.582226385925654	45	1	0.00540540540540541	185	10293	54205	CYCS
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.558653203343555	-0.582226385925654	45	1	0.00540540540540541	185	10293	8738	CRADD
R-HSA-2672351	Stimuli-sensing channels	0.560974908281877	-0.578079101229986	104	2	0.0108108108108108	185	10293	196527,444	ANO6,ASPH
R-HSA-375165	NCAM signaling for neurite out-growth	0.562875467480168	-0.574696869838574	278	5	0.027027027027027	185	10293	818,10718,5683,283455,785	CAMK2G,NRG3,PSMA2,KSR2,CACNB4
R-HSA-446652	Interleukin-1 signaling	0.566620529404009	-0.56806545961943	46	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.566620529404009	-0.56806545961943	46	1	0.00540540540540541	185	10293	3918	LAMC2
R-HSA-70153	Glucose transport	0.566620529404009	-0.56806545961943	46	1	0.00540540540540541	185	10293	57818	G6PC2
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.566620529404009	-0.56806545961943	46	1	0.00540540540540541	185	10293	23439	ATP1B4
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.571362265643953	-0.5597318297911	106	2	0.0108108108108108	185	10293	23446,55356	SLC44A1,SLC22A15
R-HSA-5578749	Transcriptional regulation by small RNAs	0.571362265643953	-0.5597318297911	106	2	0.0108108108108108	185	10293	554313,8370	HIST2H4B,HIST2H4A
R-HSA-112043	PLC beta mediated events	0.574444790361157	-0.554351286639967	47	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-8948216	Collagen chain trimerization	0.574444790361157	-0.554351286639967	47	1	0.00540540540540541	185	10293	1290	COL5A2
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.574444790361157	-0.554351286639967	47	1	0.00540540540540541	185	10293	23112	TNRC6B
R-HSA-5689603	UCH proteinases	0.57648919230946	-0.550798686526878	107	2	0.0108108108108108	185	10293	5683,221937	PSMA2,FOXK1
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.57648919230946	-0.550798686526878	107	2	0.0108108108108108	185	10293	23315,117247	SLC9A8,SLC16A10
R-HSA-112040	G-protein mediated events	0.582128541473684	-0.541063993998408	48	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-418597	G alpha (z) signalling events	0.582128541473684	-0.541063993998408	48	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-73886	Chromosome Maintenance	0.586609150961261	-0.533396522558316	109	2	0.0108108108108108	185	10293	554313,8370	HIST2H4B,HIST2H4A
R-HSA-382556	ABC-family proteins mediated transport	0.586609150961261	-0.533396522558316	109	2	0.0108108108108108	185	10293	22,5683	ABCB7,PSMA2
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	0.589674292546068	-0.52818494104825	49	1	0.00540540540540541	185	10293	22836	RHOBTB3
R-HSA-425407	SLC-mediated transmembrane transport	0.591388709505673	-0.525281762876074	287	5	0.027027027027027	185	10293	23315,55356,23446,117247,57818	SLC9A8,SLC22A15,SLC44A1,SLC16A10,G6PC2
R-HSA-8856688	Golgi-to-ER retrograde transport	0.5916020776298	-0.524921036268968	110	2	0.0108108108108108	185	10293	5049,89953	PAFAH1B2,KLC4
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.5916020776298	-0.524921036268968	110	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-2467813	Separation of Sister Chromatids	0.593145723211138	-0.522315171200036	170	3	0.0162162162162162	185	10293	5683,23063,119504	PSMA2,WAPL,ANAPC16
R-HSA-69306	DNA Replication	0.596550259243277	-0.516591784089512	111	2	0.0108108108108108	185	10293	5683,84515	PSMA2,MCM8
R-HSA-5654736	Signaling by FGFR1	0.597084508860049	-0.515696619728144	50	1	0.00540540540540541	185	10293	23768	FLRT2
R-HSA-6802949	Signaling by RAS mutants	0.597084508860049	-0.515696619728144	50	1	0.00540540540540541	185	10293	283455	KSR2
R-HSA-73887	Death Receptor Signalling	0.597084508860049	-0.515696619728144	50	1	0.00540540540540541	185	10293	841	CASP8
R-HSA-73864	RNA Polymerase I Transcription	0.601453682704229	-0.508405749517774	112	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-1227986	Signaling by ERBB2	0.604361611844349	-0.5035825650872	51	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-383280	Nuclear Receptor transcription pathway	0.604361611844349	-0.5035825650872	51	1	0.00540540540540541	185	10293	3172	HNF4A
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.61112627648309	-0.492451669342469	114	2	0.0108108108108108	185	10293	54205,498	CYCS,ATP5A1
R-HSA-449147	Signaling by Interleukins	0.611158884091217	-0.492398314185774	527	9	0.0486486486486487	185	10293	4985,3635,7334,818,10718,6597,5683,283455,54014	OPRD1,INPP5D,UBE2N,CAMK2G,NRG3,SMARCA4,PSMA2,KSR2,BRWD1
R-HSA-445717	Aquaporin-mediated transport	0.611507979904872	-0.491827274218271	52	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.611507979904872	-0.491827274218271	52	1	0.00540540540540541	185	10293	55790	CSGALNACT1
R-HSA-1280215	Cytokine Signaling in Immune system	0.611542850843284	-0.49177025134147	758	13	0.0702702702702703	185	10293	4985,693215,7334,818,3454,3635,10718,283455,5683,6597,2690,55128,54014	OPRD1,MIR630,UBE2N,CAMK2G,IFNAR1,INPP5D,NRG3,KSR2,PSMA2,SMARCA4,GHR,TRIM68,BRWD1
R-HSA-195258	RHO GTPase Effectors	0.612852926760491	-0.489630295550837	294	5	0.027027027027027	185	10293	5217,554313,89953,1856,8370	PFN2,HIST2H4B,KLC4,DVL2,HIST2H4A
R-HSA-166054	Activated TLR4 signalling	0.615895492724723	-0.484677984509255	115	2	0.0108108108108108	185	10293	7334,841	UBE2N,CASP8
R-HSA-194441	Metabolism of non-coding RNA	0.618525949231084	-0.480416132926882	53	1	0.00540540540540541	185	10293	79833	GEMIN6
R-HSA-191859	snRNP Assembly	0.618525949231084	-0.480416132926882	53	1	0.00540540540540541	185	10293	79833	GEMIN6
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.618525949231084	-0.480416132926882	53	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.618525949231084	-0.480416132926882	53	1	0.00540540540540541	185	10293	27031	NPHP3
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.618525949231084	-0.480416132926882	53	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-1474244	Extracellular matrix organization	0.621851395648223	-0.475054128536231	297	5	0.027027027027027	185	10293	10491,1290,6678,1088,3918	CRTAP,COL5A2,SPARC,CEACAM8,LAMC2
R-HSA-5663220	RHO GTPases Activate Formins	0.625299979452768	-0.469523777268684	117	2	0.0108108108108108	185	10293	5217,1856	PFN2,DVL2
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.625417814392807	-0.469335349565859	54	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.625417814392807	-0.469335349565859	54	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-189200	Hexose transport	0.625417814392807	-0.469335349565859	54	1	0.00540540540540541	185	10293	57818	G6PC2
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.625417814392807	-0.469335349565859	54	1	0.00540540540540541	185	10293	2720	GLB1
R-HSA-1592230	Mitochondrial biogenesis	0.625417814392807	-0.469335349565859	54	1	0.00540540540540541	185	10293	54205	CYCS
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.625417814392807	-0.469335349565859	54	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.625417814392807	-0.469335349565859	54	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.628171439089226	-0.464942157589228	179	3	0.0162162162162162	185	10293	22836,89953,5049	RHOBTB3,KLC4,PAFAH1B2
R-HSA-2428924	IGF1R signaling cascade	0.630726234480498	-0.460883370362649	300	5	0.027027027027027	185	10293	5683,283455,10718,3480,818	PSMA2,KSR2,NRG3,IGF1R,CAMK2G
R-HSA-2428928	IRS-related events triggered by IGF1R	0.630726234480498	-0.460883370362649	300	5	0.027027027027027	185	10293	283455,5683,818,3480,10718	KSR2,PSMA2,CAMK2G,IGF1R,NRG3
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.632185829281858	-0.458571894380883	55	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-180534	Vpu mediated degradation of CD4	0.632185829281858	-0.458571894380883	55	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.633656683922842	-0.456247979221459	301	5	0.027027027027027	185	10293	818,10718,3480,283455,5683	CAMK2G,NRG3,IGF1R,KSR2,PSMA2
R-HSA-68882	Mitotic Anaphase	0.635669511087249	-0.4530764873552	181	3	0.0162162162162162	185	10293	5683,23063,119504	PSMA2,WAPL,ANAPC16
R-HSA-381038	XBP1(S) activates chaperone genes	0.638832207622196	-0.448113444967069	56	1	0.00540540540540541	185	10293	9695	EDEM1
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.638832207622196	-0.448113444967069	56	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.638832207622196	-0.448113444967069	56	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-69610	p53-Independent DNA Damage Response	0.638832207622196	-0.448113444967069	56	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-169911	Regulation of Apoptosis	0.638832207622196	-0.448113444967069	56	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.639379199475324	-0.447257574203468	182	3	0.0162162162162162	185	10293	23063,5683,119504	WAPL,PSMA2,ANAPC16
R-HSA-69206	G1/S Transition	0.64357516160709	-0.440716457512472	121	2	0.0108108108108108	185	10293	84515,5683	MCM8,PSMA2
R-HSA-3000178	ECM proteoglycans	0.645359123875248	-0.437948335929573	57	1	0.00540540540540541	185	10293	6678	SPARC
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.645359123875248	-0.437948335929573	57	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-162582	Signal Transduction	0.651306358096108	-0.428775151315434	2550	44	0.237837837837838	185	10293	102465803,6597,112724,3480,391107,4985,841,3953,112,1856,81472,27152,554313,55701,341152,5217,842,23768,5592,283455,3918,390882,5683,89953,51684,8556,56998,8396,390436,10718,284433,195814,23229,394,657,23112,9754,989,57610,23263,818,10988,8370,23439	MIR7706,SMARCA4,RDH13,IGF1R,OR10K2,OPRD1,CASP8,LEPR,ADCY6,DVL2,OR2C3,INTU,HIST2H4B,ARHGEF40,OR2AT4,PFN2,CASP9,FLRT2,PRKG1,KSR2,LAMC2,OR7G2,PSMA2,KLC4,SUFU,CDC14A,CTNNBIP1,PIP4K2B,OR4K17,NRG3,OR10H5,SDR16C5,ARHGEF9,ARHGAP5,BMPR1A,TNRC6B,STARD8,SEPT7,RANBP10,MCF2L,CAMK2G,METAP2,HIST2H4A,ATP1B4
R-HSA-381070	IRE1alpha activates chaperones	0.651768713771226	-0.428065513468004	58	1	0.00540540540540541	185	10293	9695	EDEM1
R-HSA-69541	Stabilization of p53	0.651768713771226	-0.428065513468004	58	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.651768713771226	-0.428065513468004	58	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-4641257	Degradation of AXIN	0.651768713771226	-0.428065513468004	58	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	0.651768713771226	-0.428065513468004	58	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-179812	GRB2 events in EGFR signaling	0.652625281696984	-0.426752155614687	247	4	0.0216216216216216	185	10293	283455,5683,818,10718	KSR2,PSMA2,CAMK2G,NRG3
R-HSA-180336	SHC1 events in EGFR signaling	0.652625281696984	-0.426752155614687	247	4	0.0216216216216216	185	10293	10718,818,283455,5683	NRG3,CAMK2G,KSR2,PSMA2
R-HSA-5673001	RAF/MAP kinase cascade	0.652625281696984	-0.426752155614687	247	4	0.0216216216216216	185	10293	5683,283455,818,10718	PSMA2,KSR2,CAMK2G,NRG3
R-HSA-112412	SOS-mediated signalling	0.652625281696984	-0.426752155614687	247	4	0.0216216216216216	185	10293	10718,818,283455,5683	NRG3,CAMK2G,KSR2,PSMA2
R-HSA-6798695	Neutrophil degranulation	0.653608647616637	-0.425246504776262	487	8	0.0432432432432432	185	10293	1088,8907,2821,196527,51071,5683,5049,2720	CEACAM8,AP1M1,GPI,ANO6,DERA,PSMA2,PAFAH1B2,GLB1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.658063075065257	-0.418454493489189	59	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-2142753	Arachidonic acid metabolism	0.658063075065257	-0.418454493489189	59	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-422475	Axon guidance	0.664194820585394	-0.409179768044309	551	9	0.0486486486486487	185	10293	5683,283455,4478,80031,785,5217,10718,3785,818	PSMA2,KSR2,MSN,SEMA6D,CACNB4,PFN2,NRG3,KCNQ2,CAMK2G
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.664244268258633	-0.409105323271226	60	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-187706	Signalling to p38 via RIT and RIN	0.665038051774541	-0.40791101924973	251	4	0.0216216216216216	185	10293	10718,818,5683,283455	NRG3,CAMK2G,PSMA2,KSR2
R-HSA-170984	ARMS-mediated activation	0.665038051774541	-0.40791101924973	251	4	0.0216216216216216	185	10293	283455,5683,10718,818	KSR2,PSMA2,NRG3,CAMK2G
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.665426924845478	-0.40732645206631	126	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-5619507	Activation of HOX genes during differentiation	0.665426924845478	-0.40732645206631	126	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.665426924845478	-0.40732645206631	126	2	0.0108108108108108	185	10293	7334,841	UBE2N,CASP8
R-HSA-170968	Frs2-mediated activation	0.668094101603186	-0.40332624470338	252	4	0.0216216216216216	185	10293	10718,818,283455,5683	NRG3,CAMK2G,KSR2,PSMA2
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.670314317164636	-0.400008546507774	61	1	0.00540540540540541	185	10293	4641	MYO1C
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.671131218940163	-0.398790603841416	253	4	0.0216216216216216	185	10293	6721,137964,79993,6319	SREBF2,GPAT4,ELOVL7,SCD
R-HSA-5684996	MAPK1/MAPK3 signaling	0.671131218940163	-0.398790603841416	253	4	0.0216216216216216	185	10293	5683,283455,10718,818	PSMA2,KSR2,NRG3,CAMK2G
R-HSA-169893	Prolonged ERK activation events	0.674149371850784	-0.394303572667252	254	4	0.0216216216216216	185	10293	10718,818,5683,283455	NRG3,CAMK2G,PSMA2,KSR2
R-HSA-72187	mRNA 3'-end processing	0.676275209590565	-0.391155171008967	62	1	0.00540540540540541	185	10293	9877	ZC3H11A
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.676275209590565	-0.391155171008967	62	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-8852135	Protein ubiquitination	0.676275209590565	-0.391155171008967	62	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.676275209590565	-0.391155171008967	62	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-1483206	Glycerophospholipid biosynthesis	0.678015507153115	-0.38858511939605	129	2	0.0108108108108108	185	10293	137964,23446	GPAT4,SLC44A1
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.682128898006862	-0.382536638986865	63	1	0.00540540540540541	185	10293	2720	GLB1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.682128898006862	-0.382536638986865	63	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	0.682128898006862	-0.382536638986865	63	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.682128898006862	-0.382536638986865	63	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-167044	Signalling to RAS	0.686031810839317	-0.376831280845492	258	4	0.0216216216216216	185	10293	5683,283455,10718,818	PSMA2,KSR2,NRG3,CAMK2G
R-HSA-8873719	RAB geranylgeranylation	0.687877300143624	-0.374144799768265	64	1	0.00540540540540541	185	10293	5862	RAB2A
R-HSA-450294	MAP kinase activation in TLR cascade	0.687877300143624	-0.374144799768265	64	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.687877300143624	-0.374144799768265	64	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-114608	Platelet degranulation	0.690217917466907	-0.370747908836426	132	2	0.0108108108108108	185	10293	6678,1521	SPARC,CTSW
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.691858643162528	-0.368373617117535	260	4	0.0216216216216216	185	10293	283455,5683,10718,818	KSR2,PSMA2,NRG3,CAMK2G
R-HSA-597592	Post-translational protein modification	0.692739364618419	-0.367101447766254	1037	17	0.0918918918918919	185	10293	5862,412,5071,8693,2720,221937,10617,93183,79796,4045,7334,51128,80055,8615,10299,5683,9695	RAB2A,STS,PARK2,GALNT4,GLB1,FOXK1,STAMBP,PIGM,ALG9,LSAMP,UBE2N,SAR1B,PGAP1,USO1,MARCH6,PSMA2,EDEM1
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.693522299595705	-0.365971884595398	65	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-913709	O-linked glycosylation of mucins	0.693522299595705	-0.365971884595398	65	1	0.00540540540540541	185	10293	8693	GALNT4
R-HSA-1500931	Cell-Cell communication	0.69420048142386	-0.364994482060224	133	2	0.0108108108108108	185	10293	3918,29780	LAMC2,PARVB
R-HSA-199977	ER to Golgi Anterograde Transport	0.698140939724543	-0.359334277226602	134	2	0.0108108108108108	185	10293	8615,51128	USO1,SAR1B
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.704509457911939	-0.350253522734313	67	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.704509457911939	-0.350253522734313	67	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-1632852	Macroautophagy	0.704509457911939	-0.350253522734313	67	1	0.00540540540540541	185	10293	128866	CHMP4B
R-HSA-8848021	Signaling by PTK6	0.704509457911939	-0.350253522734313	67	1	0.00540540540540541	185	10293	10718	NRG3
R-HSA-162909	Host Interactions of HIV factors	0.705896415879967	-0.348286771970046	136	2	0.0108108108108108	185	10293	5683,8907	PSMA2,AP1M1
R-HSA-187687	Signalling to ERKs	0.706091362695623	-0.348010640944194	265	4	0.0216216216216216	185	10293	283455,5683,10718,818	KSR2,PSMA2,NRG3,CAMK2G
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.709711886276401	-0.342896185280332	137	2	0.0108108108108108	185	10293	1521,6678	CTSW,SPARC
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.709855218752352	-0.342694246990934	68	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-373755	Semaphorin interactions	0.709855218752352	-0.342694246990934	68	1	0.00540540540540541	185	10293	80031	SEMA6D
R-HSA-381753	Olfactory Signaling Pathway	0.710098661900848	-0.342351358177152	391	6	0.0324324324324324	185	10293	81472,390882,391107,341152,284433,390436	OR2C3,OR7G2,OR10K2,OR2AT4,OR10H5,OR4K17
R-HSA-2871796	FCERI mediated MAPK activation	0.71165065830861	-0.340168136420458	267	4	0.0216216216216216	185	10293	10718,818,5683,283455	NRG3,CAMK2G,PSMA2,KSR2
R-HSA-69615	G1/S DNA Damage Checkpoints	0.715104782023211	-0.335326198741068	69	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-909733	Interferon alpha/beta signaling	0.715104782023211	-0.335326198741068	69	1	0.00540540540540541	185	10293	3454	IFNAR1
R-HSA-388841	Costimulation by the CD28 family	0.715104782023211	-0.335326198741068	69	1	0.00540540540540541	185	10293	5133	PDCD1
R-HSA-5358346	Hedgehog ligand biogenesis	0.715104782023211	-0.335326198741068	69	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-1169091	Activation of NF-kappaB in B cells	0.720259869592107	-0.328143202102559	70	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-8853659	RET signaling	0.725214903993688	-0.321287248749346	272	4	0.0216216216216216	185	10293	818,10718,283455,5683	CAMK2G,NRG3,KSR2,PSMA2
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.725322172669038	-0.321139346738054	71	1	0.00540540540540541	185	10293	9877	ZC3H11A
R-HSA-5619084	ABC transporter disorders	0.725322172669038	-0.321139346738054	71	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-73856	RNA Polymerase II Transcription Termination	0.725322172669038	-0.321139346738054	71	1	0.00540540540540541	185	10293	9877	ZC3H11A
R-HSA-5658442	Regulation of RAS by GAPs	0.730293352277079	-0.31430897312641	72	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.735175039956987	-0.307646658521073	73	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-453279	Mitotic G1-G1/S phases	0.738773069100781	-0.302764483540209	145	2	0.0108108108108108	185	10293	5683,84515	PSMA2,MCM8
R-HSA-69202	Cyclin E associated events during G1/S transition	0.739968838167343	-0.301147204255269	74	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.744676320777639	-0.294805623766321	75	1	0.00540540540540541	185	10293	9877	ZC3H11A
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.752355341891148	-0.284546537528451	149	2	0.0108108108108108	185	10293	8370,554313	HIST2H4A,HIST2H4B
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.753838495261381	-0.282577131183765	77	1	0.00540540540540541	185	10293	23439	ATP1B4
R-HSA-5619115	Disorders of transmembrane transporters	0.758296196743858	-0.276681208791112	78	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-6807878	COPI-mediated anterograde transport	0.762673602872887	-0.270925120515926	79	1	0.00540540540540541	185	10293	8615	USO1
R-HSA-168898	Toll-Like Receptors Cascades	0.765328567162907	-0.267450037804781	153	2	0.0108108108108108	185	10293	7334,841	UBE2N,CASP8
R-HSA-422356	Regulation of insulin secretion	0.766972152270672	-0.265304785613419	80	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.775338307575207	-0.254455818975011	82	1	0.00540540540540541	185	10293	89953	KLC4
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.783405667002921	-0.244104623920403	84	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.783405667002921	-0.244104623920403	84	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.783405667002921	-0.244104623920403	84	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.783686370608427	-0.243746376157322	159	2	0.0108108108108108	185	10293	54205,498	CYCS,ATP5A1
R-HSA-112399	IRS-mediated signalling	0.783780644958986	-0.24362608737327	296	4	0.0216216216216216	185	10293	818,10718,283455,5683	CAMK2G,NRG3,KSR2,PSMA2
R-HSA-1430728	Metabolism	0.784501520885017	-0.242706768142965	2162	35	0.189189189189189	185	10293	412,5549,5261,26119,6319,54205,57818,1582,91012,51071,498,204219,51128,8396,137964,158,54577,113235,5683,3635,79993,2720,113026,55790,84725,126282,200879,112,2821,4338,6721,22,253782,55034,23446	STS,PRELP,PHKG2,LDLRAP1,SCD,CYCS,G6PC2,CYP8B1,CERS5,DERA,ATP5A1,CERS3,SAR1B,PIP4K2B,GPAT4,ADSL,UGT1A7,SLC46A1,PSMA2,INPP5D,ELOVL7,GLB1,PLCD3,CSGALNACT1,PLEKHA8,TNFAIP8L1,LIPH,ADCY6,GPI,MOCS2,SREBF2,ABCB7,CERS6,MOCOS,SLC44A1
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.787330630443772	-0.239107003866099	85	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-3781865	Diseases of glycosylation	0.787330630443772	-0.239107003866099	85	1	0.00540540540540541	185	10293	5549	PRELP
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.787330630443772	-0.239107003866099	85	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-111885	Opioid Signalling	0.787330630443772	-0.239107003866099	85	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-168249	Innate Immune System	0.789775548504067	-0.236006489707252	1287	20	0.108108108108108	185	10293	4641,5683,283455,196527,2821,112,7334,10718,841,8396,1088,8907,2720,5049,51071,23112,818,538,54476,842	MYO1C,PSMA2,KSR2,ANO6,GPI,ADCY6,UBE2N,NRG3,CASP8,PIP4K2B,CEACAM8,AP1M1,GLB1,PAFAH1B2,DERA,TNRC6B,CAMK2G,ATP7A,RNF216,CASP9
R-HSA-74751	Insulin receptor signalling cascade	0.790358987280301	-0.235268022457109	299	4	0.0216216216216216	185	10293	283455,5683,10718,818	KSR2,PSMA2,NRG3,CAMK2G
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.791184846087906	-0.234223651930988	86	1	0.00540540540540541	185	10293	4641	MYO1C
R-HSA-5368286	Mitochondrial translation initiation	0.794969582385065	-0.229451426210643	87	1	0.00540540540540541	185	10293	63931	MRPS14
R-HSA-1236974	ER-Phagosome pathway	0.794969582385065	-0.229451426210643	87	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.794969582385065	-0.229451426210643	87	1	0.00540540540540541	185	10293	9877	ZC3H11A
R-HSA-5419276	Mitochondrial translation termination	0.794969582385065	-0.229451426210643	87	1	0.00540540540540541	185	10293	63931	MRPS14
R-HSA-5389840	Mitochondrial translation elongation	0.798686085152858	-0.224787295080022	88	1	0.00540540540540541	185	10293	63931	MRPS14
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.798686085152858	-0.224787295080022	88	1	0.00540540540540541	185	10293	6721	SREBF2
R-HSA-5688426	Deubiquitination	0.798882000142262	-0.224542028549988	303	4	0.0216216216216216	185	10293	5071,10617,5683,221937	PARK2,STAMBP,PSMA2,FOXK1
R-HSA-948021	Transport to the Golgi and subsequent modification	0.80077800064156	-0.222171523084805	165	2	0.0108108108108108	185	10293	51128,8615	SAR1B,USO1
R-HSA-351202	Metabolism of polyamines	0.80233557798203	-0.220228332220032	89	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-3371556	Cellular response to heat stress	0.80233557798203	-0.220228332220032	89	1	0.00540540540540541	185	10293	818	CAMK2G
R-HSA-190236	Signaling by FGFR	0.80233557798203	-0.220228332220032	89	1	0.00540540540540541	185	10293	23768	FLRT2
R-HSA-5663202	Diseases of signal transduction	0.80402849472961	-0.218120569225213	372	5	0.027027027027027	185	10293	10718,283455,842,5683,23164	NRG3,KSR2,CASP9,PSMA2,MPRIP
R-HSA-162906	HIV Infection	0.805796934804668	-0.215923510147901	238	3	0.0162162162162162	185	10293	8907,5683,128866	AP1M1,PSMA2,CHMP4B
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.805919262628302	-0.215771711929252	90	1	0.00540540540540541	185	10293	414918	DENND6B
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.80943831942987	-0.211414704654012	91	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-418346	Platelet homeostasis	0.80943831942987	-0.211414704654012	91	1	0.00540540540540541	185	10293	5592	PRKG1
R-HSA-381119	Unfolded Protein Response (UPR)	0.812893907611937	-0.207154672891799	92	1	0.00540540540540541	185	10293	9695	EDEM1
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.816287165847225	-0.202989066996549	93	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.816287165847225	-0.202989066996549	93	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.816287165847225	-0.202989066996549	93	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-611105	Respiratory electron transport	0.816287165847225	-0.202989066996549	93	1	0.00540540540540541	185	10293	54205	CYCS
R-HSA-5368287	Mitochondrial translation	0.819619212343853	-0.198915421769812	94	1	0.00540540540540541	185	10293	63931	MRPS14
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.822891145452845	-0.194931352602325	95	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.822891145452845	-0.194931352602325	95	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.822891145452845	-0.194931352602325	95	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.822891145452845	-0.194931352602325	95	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-73894	DNA Repair	0.824677170258225	-0.192763278006623	316	4	0.0216216216216216	185	10293	64421,8370,7334,554313	DCLRE1C,HIST2H4A,UBE2N,HIST2H4B
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.829258967078826	-0.187222787732794	97	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-15869	Metabolism of nucleotides	0.829258967078826	-0.187222787732794	97	1	0.00540540540540541	185	10293	158	ADSL
R-HSA-6803157	Antimicrobial peptides	0.829258967078826	-0.187222787732794	97	1	0.00540540540540541	185	10293	538	ATP7A
R-HSA-390466	Chaperonin-mediated protein folding	0.835399031459392	-0.179845786293218	99	1	0.00540540540540541	185	10293	10382	TUBB4A
R-HSA-74752	Signaling by Insulin receptor	0.839158825275808	-0.175355287360403	324	4	0.0216216216216216	185	10293	5683,283455,818,10718	PSMA2,KSR2,CAMK2G,NRG3
R-HSA-2187338	Visual phototransduction	0.8413194420605	-0.172783855147044	101	1	0.00540540540540541	185	10293	10988	METAP2
R-HSA-1236975	Antigen processing-Cross presentation	0.847028015569991	-0.166021508643334	103	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.847028015569991	-0.166021508643334	103	1	0.00540540540540541	185	10293	23063	WAPL
R-HSA-74160	Gene Expression	0.848103517629167	-0.164752577964593	1824	28	0.151351351351351	185	10293	9877,104,8396,2821,5683,146540,79833,4641,10520,4849,284443,54205,163049,3172,27300,85456,9652,8370,8738,169841,23439,84671,51742,23112,554313,3181,54811,7652	ZC3H11A,ADARB1,PIP4K2B,GPI,PSMA2,ZNF785,GEMIN6,MYO1C,ZNF211,CNOT3,ZNF493,CYCS,ZNF791,HNF4A,ZNF544,TNKS1BP1,TTC37,HIST2H4A,CRADD,ZNF169,ATP1B4,ZNF347,ARID4B,TNRC6B,HIST2H4B,HNRNPA2B1,ZNF562,ZNF99
R-HSA-391251	Protein folding	0.852532291979441	-0.159544191387093	105	1	0.00540540540540541	185	10293	10382	TUBB4A
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.852632474745514	-0.159426686301199	332	4	0.0216216216216216	185	10293	10718,818,283455,5683	NRG3,CAMK2G,KSR2,PSMA2
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.855210101763854	-0.15640810717566	106	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-156580	Phase II conjugation	0.855210101763854	-0.15640810717566	106	1	0.00540540540540541	185	10293	54577	UGT1A7
R-HSA-211945	Phase 1 - Functionalization of compounds	0.862956787997381	-0.147390660997791	109	1	0.00540540540540541	185	10293	1582	CYP8B1
R-HSA-194138	Signaling by VEGF	0.865144223852589	-0.144859053171063	340	4	0.0216216216216216	185	10293	818,10718,283455,5683	CAMK2G,NRG3,KSR2,PSMA2
R-HSA-1474228	Degradation of the extracellular matrix	0.867890790037111	-0.141689390167122	111	1	0.00540540540540541	185	10293	3918	LAMC2
R-HSA-6785807	Interleukin-4 and 13 signaling	0.867890790037111	-0.141689390167122	111	1	0.00540540540540541	185	10293	4985	OPRD1
R-HSA-163685	Integration of energy metabolism	0.867890790037111	-0.141689390167122	111	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-68877	Mitotic Prometaphase	0.867890790037111	-0.141689390167122	111	1	0.00540540540540541	185	10293	23063	WAPL
R-HSA-5696398	Nucleotide Excision Repair	0.870291124338543	-0.138927497631706	112	1	0.00540540540540541	185	10293	7334	UBE2N
R-HSA-157118	Signaling by NOTCH	0.870291124338543	-0.138927497631706	112	1	0.00540540540540541	185	10293	23112	TNRC6B
R-HSA-5173105	O-linked glycosylation	0.874962429922748	-0.133574330777497	114	1	0.00540540540540541	185	10293	8693	GALNT4
R-HSA-1989781	PPARA activates gene expression	0.895924796237967	-0.109898802299885	124	1	0.00540540540540541	185	10293	6721	SREBF2
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.901502803301711	-0.103692126746582	127	1	0.00540540540540541	185	10293	6721	SREBF2
R-HSA-211859	Biological oxidations	0.912040921913834	-0.092070419394902	222	2	0.0108108108108108	185	10293	1582,54577	CYP8B1,UGT1A7
R-HSA-162599	Late Phase of HIV Life Cycle	0.920994200470511	-0.0823015397385013	139	1	0.00540540540540541	185	10293	128866	CHMP4B
R-HSA-5663205	Infectious disease	0.92451611775097	-0.0784847942874912	390	4	0.0216216216216216	185	10293	22987,128866,8907,5683	SV2C,CHMP4B,AP1M1,PSMA2
R-HSA-418555	G alpha (s) signalling events	0.930538628261455	-0.0719916903155425	146	1	0.00540540540540541	185	10293	112	ADCY6
R-HSA-418594	G alpha (i) signalling events	0.934799677356673	-0.067423021464399	242	2	0.0108108108108108	185	10293	112,4985	ADCY6,OPRD1
R-HSA-162587	HIV Life Cycle	0.937800815447016	-0.0642177027951286	152	1	0.00540540540540541	185	10293	128866	CHMP4B
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.939553257418987	-0.0623507747539042	247	2	0.0108108108108108	185	10293	9877,3181	ZC3H11A,HNRNPA2B1
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.942217498915937	-0.0595191404879644	156	1	0.00540540540540541	185	10293	89953	KLC4
R-HSA-109582	Hemostasis	0.942334706206248	-0.0593947530710025	632	7	0.0378378378378378	185	10293	6678,1088,1521,5675,5592,3635,89953	SPARC,CEACAM8,CTSW,PSG6,PRKG1,INPP5D,KLC4
R-HSA-388396	GPCR downstream signaling	0.942575288458436	-0.0591394811968279	974	12	0.0648648648648649	185	10293	284433,390436,112,391107,4985,23263,341152,55701,23229,81472,390882,102465803	OR10H5,OR4K17,ADCY6,OR10K2,OPRD1,MCF2L,OR2AT4,ARHGEF40,ARHGEF9,OR2C3,OR7G2,MIR7706
R-HSA-392499	Metabolism of proteins	0.944767419176498	-0.0568164990537678	1622	22	0.118918918918919	185	10293	9695,5683,10382,10299,8615,80055,79145,51128,7334,4045,79796,93183,554313,10617,498,2720,221937,8693,5071,5862,8370,412	EDEM1,PSMA2,TUBB4A,MARCH6,USO1,PGAP1,CHCHD7,SAR1B,UBE2N,LSAMP,ALG9,PIGM,HIST2H4B,STAMBP,ATP5A1,GLB1,FOXK1,GALNT4,PARK2,RAB2A,HIST2H4A,STS
R-HSA-73857	RNA Polymerase II Transcription	0.945324003256277	-0.0562275496630017	159	1	0.00540540540540541	185	10293	9877	ZC3H11A
R-HSA-5633007	Regulation of TP53 Activity	0.94826434991166	-0.0531219654807984	162	1	0.00540540540540541	185	10293	8396	PIP4K2B
R-HSA-1266738	Developmental Biology	0.95816016493735	-0.0427403282032264	1077	13	0.0702702702702703	185	10293	554313,80031,283455,4478,5683,6721,785,5217,8370,3785,10718,3172,818	HIST2H4B,SEMA6D,KSR2,MSN,PSMA2,SREBF2,CACNB4,PFN2,HIST2H4A,KCNQ2,NRG3,HNF4A,CAMK2G
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.961880553763864	-0.0388650005121061	445	4	0.0216216216216216	185	10293	5683,283455,10718,818	PSMA2,KSR2,NRG3,CAMK2G
R-HSA-76002	Platelet activation, signaling and aggregation	0.964719265314174	-0.0359181367405207	282	2	0.0108108108108108	185	10293	6678,1521	SPARC,CTSW
R-HSA-372790	Signaling by GPCR	0.966297806927989	-0.0342832035354993	1301	16	0.0864864864864865	185	10293	5683,390882,283455,102465803,112,390436,284433,10718,391107,4985,55701,23263,341152,23229,81472,818	PSMA2,OR7G2,KSR2,MIR7706,ADCY6,OR4K17,OR10H5,NRG3,OR10K2,OPRD1,ARHGEF40,MCF2L,OR2AT4,ARHGEF9,OR2C3,CAMK2G
R-HSA-72163	mRNA Splicing - Major Pathway	0.967382264946627	-0.0331615514606726	187	1	0.00540540540540541	185	10293	3181	HNRNPA2B1
R-HSA-375276	Peptide ligand-binding receptors	0.967979363806475	-0.0325445103145404	188	1	0.00540540540540541	185	10293	4985	OPRD1
R-HSA-72172	mRNA Splicing	0.971865409568017	-0.0285379516318264	195	1	0.00540540540540541	185	10293	3181	HNRNPA2B1
R-HSA-1643685	Disease	0.976518566213929	-0.0237615158262518	861	9	0.0486486486486487	185	10293	283455,5683,128866,8907,842,23164,22987,10718,5549	KSR2,PSMA2,CHMP4B,AP1M1,CASP9,MPRIP,SV2C,NRG3,PRELP
R-HSA-5689880	Ub-specific processing proteases	0.983857047821891	-0.0162746690873209	225	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.997351981265352	-0.00265153093788109	322	1	0.00540540540540541	185	10293	4985	OPRD1
R-HSA-71291	Metabolism of amino acids and derivatives	0.998773209778387	-0.00122754334474923	363	1	0.00540540540540541	185	10293	5683	PSMA2
R-HSA-500792	GPCR ligand binding	0.999775943149788	-0.000224081954697898	453	1	0.00540540540540541	185	10293	4985	OPRD1
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-164525	Plus-strand DNA synthesis	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-163316	Mitochondrial transcription termination	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-6809583	Retinoid metabolism disease events	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1483076	Synthesis of CL	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-169131	Inhibition of PKR	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-164516	Minus-strand DNA synthesis	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-3248023	Regulation by TREX1	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-389542	NADPH regeneration	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-8853333	Signaling by FGFR2 fusions	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1300645	Acrosome Reaction	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-140180	COX reactions	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-162585	Uncoating of the HIV Virion	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-2408552	Methylation of MeSeH for excretion	0.999999999974812	-2.51876124124362e-11	1	0	0	185	10293
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-156584	Cytosolic sulfonation of small molecules	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-110320	Translesion Synthesis by POLH	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-3928664	Ephrin signaling	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-5576886	Phase 4 - resting membrane potential	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-190861	Gap junction assembly	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-8876725	Protein methylation	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999974968	-2.50320066870075e-11	19	0	0	185	10293
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-165158	Activation of AKT2	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-8848584	Wax biosynthesis	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-173736	Alternative complement activation	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-390650	Histamine receptors	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-888593	Reuptake of GABA	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-8849474	PTK6 Activates STAT3	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-442745	Activation of CaMK IV	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-447115	Interleukin-12 signaling	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-1296053	Classical Kir channels	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-8935690	Miscellaneous digestion events	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-6783984	Glycine degradation	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-1296061	HCN channels	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-173107	Binding and entry of HIV virion	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-417973	Adenosine P1 receptors	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-209563	Axonal growth stimulation	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-4551638	SUMOylation of chromatin organization proteins	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-399710	Activation of AMPA receptors	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-428776	Class II GLUTs	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-209905	Catecholamine biosynthesis	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-140179	Amine Oxidase reactions	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-5083630	Defective LFNG causes SCDO3	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-167060	NGF processing	0.999999999978298	-2.17023957276282e-11	4	0	0	185	10293
R-HSA-1483213	Synthesis of PE	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-209560	NF-kB is activated and signals survival	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-69109	Leading Strand Synthesis	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-209952	Peptide hormone biosynthesis	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-2024101	CS/DS degradation	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-162594	Early Phase of HIV Life Cycle	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-190322	FGFR4 ligand binding and activation	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-69091	Polymerase switching	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-174403	Glutathione synthesis and recycling	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-209543	p75NTR recruits signalling complexes	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-428540	Activation of Rac	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-877312	Regulation of IFNG signaling	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-177504	Retrograde neurotrophin signalling	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-418885	DCC mediated attractive signaling	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-69166	Removal of the Flap Intermediate	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999979267	-2.07327592025486e-11	14	0	0	185	10293
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.999999999984016	-1.59835001038368e-11	36	0	0	185	10293
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.999999999984016	-1.59835001038368e-11	36	0	0	185	10293
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.999999999984016	-1.59835001038368e-11	36	0	0	185	10293
R-HSA-177243	Interactions of Rev with host cellular proteins	0.999999999984016	-1.59835001038368e-11	36	0	0	185	10293
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.999999999984016	-1.59835001038368e-11	36	0	0	185	10293
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.999999999984016	-1.59835001038368e-11	36	0	0	185	10293
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-6806664	Metabolism of vitamin K	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-977442	GABA A (rho) receptor activation	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-844455	The NLRP1 inflammasome	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-193681	Ceramide signalling	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-217271	FMO oxidises nucleophiles	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-8849472	PTK6 Down-Regulation	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-191650	Regulation of gap junction activity	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-1296067	Potassium transport channels	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5653890	Lactose synthesis	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-163282	Mitochondrial transcription initiation	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-73927	Depurination	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-198745	Signalling to STAT3	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-844615	The AIM2 inflammasome	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-110331	Cleavage of the damaged purine	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-77108	Utilization of Ketone Bodies	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-351200	Interconversion of polyamines	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-265473	Trafficking of dietary sterols	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-8875791	MET activates STAT3	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999986642	-1.33581340848555e-11	3	0	0	185	10293
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.999999999988158	-1.1841561596844e-11	35	0	0	185	10293
R-HSA-113418	Formation of the Early Elongation Complex	0.999999999988158	-1.1841561596844e-11	35	0	0	185	10293
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.999999999988158	-1.1841561596844e-11	35	0	0	185	10293
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.999999999988158	-1.1841561596844e-11	35	0	0	185	10293
R-HSA-4791275	Signaling by WNT in cancer	0.999999999988158	-1.1841561596844e-11	35	0	0	185	10293
R-HSA-5693537	Resolution of D-Loop Structures	0.999999999988158	-1.1841561596844e-11	35	0	0	185	10293
R-HSA-933541	TRAF6 mediated IRF7 activation	0.999999999988158	-1.1841561596844e-11	35	0	0	185	10293
R-HSA-6804757	Regulation of TP53 Degradation	0.999999999988158	-1.1841561596844e-11	35	0	0	185	10293
R-HSA-156902	Peptide chain elongation	0.999999999990408	-9.59153818705857e-12	92	0	0	185	10293
R-HSA-373080	Class B/2 (Secretin family receptors)	0.999999999990408	-9.59153818705857e-12	92	0	0	185	10293
R-HSA-192823	Viral mRNA Translation	0.999999999990408	-9.59153818705857e-12	92	0	0	185	10293
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.999999999991541	-8.45939441490582e-12	88	0	0	185	10293
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-6804760	Regulation of TP53 Activity through Methylation	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-69186	Lagging Strand Synthesis	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-418217	G beta:gamma signalling through PLC beta	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-1643713	Signaling by EGFR in Cancer	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-5654720	PI-3K cascade:FGFR4	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-194223	HDL-mediated lipid transport	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-190241	FGFR2 ligand binding and activation	0.999999999992545	-7.45474960265447e-12	20	0	0	185	10293
R-HSA-114604	GPVI-mediated activation cascade	0.999999999992756	-7.24406273567769e-12	54	0	0	185	10293
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.999999999992756	-7.24406273567769e-12	54	0	0	185	10293
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-3215018	Processing and activation of SUMO	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-190377	FGFR2b ligand binding and activation	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-8875656	MET receptor recycling	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-209968	Thyroxine biosynthesis	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-425381	Bicarbonate transporters	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-727802	Transport of nucleotide sugars	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-427601	Multifunctional anion exchangers	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-190873	Gap junction degradation	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-110056	MAPK3 (ERK1) activation	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-2046105	Linoleic acid (LA) metabolism	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-74749	Signal attenuation	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-428643	Organic anion transporters	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-74259	Purine catabolism	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-196108	Pregnenolone biosynthesis	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-8868766	rRNA processing in the mitochondrion	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-70635	Urea cycle	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-418886	Netrin mediated repulsion signals	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-3229121	Glycogen storage diseases	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-2161522	Abacavir transport and metabolism	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-399997	Acetylcholine regulates insulin secretion	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.999999999995362	-4.63787733028802e-12	10	0	0	185	10293
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.999999999997383	-2.61691137339678e-12	78	0	0	185	10293
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-1462054	Alpha-defensins	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-156587	Amino Acid conjugation	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-1300642	Sperm Motility And Taxes	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-162592	Integration of provirus	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-196025	Formation of annular gap junctions	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-75094	Formation of the Editosome	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-2474795	Diseases associated with visual transduction	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-419771	Opsins	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-8854691	Interleukin-19, 20, 22, 24	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-390696	Adrenoceptors	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-166665	Terminal pathway of complement	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-193697	p75NTR regulates axonogenesis	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-2453864	Retinoid cycle disease events	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-447041	CHL1 interactions	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-2179392	EGFR Transactivation by Gastrin	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-159424	Conjugation of carboxylic acids	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-74182	Ketone body metabolism	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-391908	Prostanoid ligand receptors	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999997836	-2.16430648943795e-12	9	0	0	185	10293
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-8942233	Intestinal infectious diseases	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-844623	The IPAF inflammasome	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-71737	Pyrophosphate hydrolysis	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-168268	Virus Assembly and Release	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-75896	Plasmalogen biosynthesis	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-198765	Signalling to ERK5	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5652227	Fructose biosynthesis	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-165160	PDE3B signalling	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-192905	vRNP Assembly	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-156582	Acetylation	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-8849175	Threonine catabolism	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-70688	Proline catabolism	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-111995	phospho-PLA2 pathway	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-380612	Metabolism of serotonin	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-888568	GABA synthesis	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-187042	TRKA activation by NGF	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-6804754	Regulation of TP53 Expression	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-1483101	Synthesis of PS	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-351143	Agmatine biosynthesis	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-1483152	Hydrolysis of LPE	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-8854521	Interaction between PHLDA1 and AURKA	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999997955	-2.04501519884825e-12	2	0	0	185	10293
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-1483115	Hydrolysis of LPC	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-444821	Relaxin receptors	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-164944	Nef and signal transduction	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-448424	Interleukin-17 signaling	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-77111	Synthesis of Ketone Bodies	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-5576890	Phase 3 - rapid repolarisation	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-73942	DNA Damage Reversal	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-5632681	Ligand-receptor interactions	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-70921	Histidine catabolism	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-73928	Depyrimidination	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-196783	Coenzyme A biosynthesis	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-72731	Recycling of eIF2:GDP	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-804914	Transport of fatty acids	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-400451	Free fatty acids regulate insulin secretion	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-1483148	Synthesis of PG	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-2142789	Ubiquinol biosynthesis	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-977347	Serine biosynthesis	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-68952	DNA replication initiation	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-6787450	tRNA modification in the mitochondrion	0.999999999998227	-1.77274033773365e-12	8	0	0	185	10293
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-166208	mTORC1-mediated signalling	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-373753	Nephrin interactions	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-198753	ERK/MAPK targets	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-5655332	Signaling by FGFR3 in disease	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-1482801	Acyl chain remodelling of PS	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-202131	Metabolism of nitric oxide	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-4641263	Regulation of FZD by ubiquitination	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-166663	Initial triggering of complement	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-203765	eNOS activation and regulation	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.999999999998669	-1.33087703273543e-12	22	0	0	185	10293
R-HSA-379724	tRNA Aminoacylation	0.999999999998975	-1.02447152613149e-12	45	0	0	185	10293
R-HSA-8854214	TBC/RABGAPs	0.999999999998975	-1.02447152613149e-12	45	0	0	185	10293
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999998975	-1.02447152613149e-12	45	0	0	185	10293
R-HSA-166658	Complement cascade	0.999999999998975	-1.02447152613149e-12	45	0	0	185	10293
R-HSA-6811438	Intra-Golgi traffic	0.999999999998975	-1.02447152613149e-12	45	0	0	185	10293
R-HSA-70268	Pyruvate metabolism	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-264876	Insulin processing	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-190828	Gap junction trafficking	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-5621480	Dectin-2 family	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-6803529	FGFR2 alternative splicing	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-1368082	RORA activates gene expression	0.999999999999277	-7.22498520493988e-13	28	0	0	185	10293
R-HSA-6782135	Dual incision in TC-NER	0.999999999999278	-7.22162537914728e-13	66	0	0	185	10293
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.999999999999905	-9.47072768368257e-14	70	0	0	185	10293
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-75205	Dissolution of Fibrin Clot	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-432047	Passive transport by Aquaporins	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-190372	FGFR3c ligand binding and activation	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-75892	Platelet Adhesion to exposed collagen	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-2168880	Scavenging of heme from plasma	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-1502540	Signaling by Activin	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-71240	Tryptophan catabolism	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-2995410	Nuclear Envelope Reassembly	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-2029481	FCGR activation	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-375281	Hormone ligand-binding receptors	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-171007	p38MAPK events	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-202670	ERKs are inactivated	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-190375	FGFR2c ligand binding and activation	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-2408517	SeMet incorporation into proteins	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-425561	Sodium/Calcium exchangers	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-3270619	IRF3-mediated induction of type I IFN	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-5210891	Uptake and function of anthrax toxins	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-190239	FGFR3 ligand binding and activation	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-1480926	O2/CO2 exchange in erythrocytes	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-175474	Assembly Of The HIV Virion	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-350054	Notch-HLH transcription pathway	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-5626467	RHO GTPases activate IQGAPs	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-74217	Purine salvage	1.00000000000017	1.66487917731845e-13	13	0	0	185	10293
R-HSA-2980766	Nuclear Envelope Breakdown	1.00000000000028	2.8204824661114e-13	52	0	0	185	10293
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	1.00000000000028	2.8204824661114e-13	52	0	0	185	10293
R-HSA-5654738	Signaling by FGFR2	1.00000000000043	4.27800738690511e-13	75	0	0	185	10293
R-HSA-167172	Transcription of the HIV genome	1.00000000000119	1.18848393279433e-12	77	0	0	185	10293
R-HSA-1482839	Acyl chain remodelling of PE	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-390918	Peroxisomal lipid metabolism	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-72086	mRNA Capping	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-5218920	VEGFR2 mediated vascular permeability	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-375170	CDO in myogenesis	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-202040	G-protein activation	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-5654732	Negative regulation of FGFR3 signaling	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-525793	Myogenesis	1.0000000000012	1.19754376635151e-12	29	0	0	185	10293
R-HSA-400685	Sema4D in semaphorin signaling	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-180024	DARPP-32 events	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-6783589	Interleukin-6 family signaling	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-5654716	Downstream signaling of activated FGFR4	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-114508	Effects of PIP2 hydrolysis	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-380994	ATF4 activates genes	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-77387	Insulin receptor recycling	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-977606	Regulation of Complement cascade	1.00000000000129	1.28952545157268e-12	27	0	0	185	10293
R-HSA-418038	Nucleotide-like (purinergic) receptors	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-110312	Translesion synthesis by REV1	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-399956	CRMPs in Sema3A signaling	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-1834941	STING mediated induction of host immune responses	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-5686938	Regulation of TLR by endogenous ligand	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-1295596	Spry regulation of FGF signaling	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-1433559	Regulation of KIT signaling	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-190242	FGFR1 ligand binding and activation	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-159418	Recycling of bile acids and salts	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-5637812	Signaling by EGFRvIII in Cancer	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-5637810	Constitutive Signaling by EGFRvIII	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-399954	Sema3A PAK dependent Axon repulsion	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-918233	TRAF3-dependent IRF activation pathway	1.00000000000158	1.57919638080759e-12	16	0	0	185	10293
R-HSA-167290	Pausing and recovery of HIV elongation	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-5675221	Negative regulation of MAPK pathway	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-1442490	Collagen degradation	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-168276	NS1 Mediated Effects on Host Pathways	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-5654741	Signaling by FGFR3	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-167287	HIV elongation arrest and recovery	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-109703	PKB-mediated events	1.00000000000164	1.64372511112194e-12	40	0	0	185	10293
R-HSA-112382	Formation of RNA Pol II elongation complex	1.00000000000221	2.2101767808031e-12	65	0	0	185	10293
R-HSA-75955	RNA Polymerase II Transcription Elongation	1.00000000000221	2.2101767808031e-12	65	0	0	185	10293
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	1.00000000000221	2.2101767808031e-12	65	0	0	185	10293
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	1.00000000000238	2.38276242903888e-12	59	0	0	185	10293
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	1.00000000000238	2.38276242903888e-12	59	0	0	185	10293
R-HSA-72764	Eukaryotic Translation Termination	1.0000000000027	2.70484619391513e-12	96	0	0	185	10293
R-HSA-156842	Eukaryotic Translation Elongation	1.0000000000027	2.70484619391513e-12	96	0	0	185	10293
R-HSA-912631	Regulation of signaling by CBL	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-69205	G1/S-Specific Transcription	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-209776	Amine-derived hormones	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-73780	RNA Polymerase III Chain Elongation	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-1912420	Pre-NOTCH Processing in Golgi	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-210993	Tie2 Signaling	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-5635838	Activation of SMO	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-1369062	ABC transporters in lipid homeostasis	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-5654704	SHC-mediated cascade:FGFR3	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-5654710	PI-3K cascade:FGFR3	1.00000000000295	2.9534298270149e-12	18	0	0	185	10293
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	1.00000000000329	3.29051317692136e-12	69	0	0	185	10293
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.00000000000331	3.31166290238966e-12	79	0	0	185	10293
R-HSA-109704	PI3K Cascade	1.00000000000331	3.31166290238966e-12	79	0	0	185	10293
R-HSA-8865999	MET activates PTPN11	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-444209	Free fatty acid receptors	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-389599	Alpha-oxidation of phytanate	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-426048	Arachidonate production from DAG	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-1614517	Sulfide oxidation to sulfate	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-391906	Leukotriene receptors	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-157881	Cyclin B2 mediated events	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-427652	Sodium-coupled phosphate cotransporters	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-3000471	Scavenging by Class B Receptors	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-5662702	Melanin biosynthesis	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-561048	Organic anion transport	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-70370	Galactose catabolism	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-166187	Mitochondrial Uncoupling Proteins	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-71032	Propionyl-CoA catabolism	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-69478	G2/M DNA replication checkpoint	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-203641	NOSTRIN mediated eNOS trafficking	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-167827	The proton buffering model	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8849473	PTK6 Expression	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-196819	Vitamin B1 (thiamin) metabolism	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-1483226	Synthesis of PI	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-2161517	Abacavir transmembrane transport	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8853383	Lysosomal oligosaccharide catabolism	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-187024	NGF-independant TRKA activation	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-114516	Disinhibition of SNARE formation	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8875513	MET interacts with TNS proteins	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-111448	Activation of NOXA and translocation to mitochondria	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-1169092	Activation of RAS in B cells	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-74713	IRS activation	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-1306955	GRB7 events in ERBB2 signaling	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8852405	Signaling by MST1	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-112307	Transmission across Electrical Synapses	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-6785470	tRNA processing in the mitochondrion	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-1300652	Sperm:Oocyte Membrane Binding	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-390648	Muscarinic acetylcholine receptors	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-390651	Dopamine receptors	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-71262	Carnitine synthesis	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-167826	The fatty acid cycling model	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-70350	Fructose catabolism	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-112303	Electric Transmission Across Gap Junctions	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-209931	Serotonin and melatonin biosynthesis	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-2142850	Hyaluronan biosynthesis and export	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-68911	G2 Phase	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-380095	Tachykinin receptors bind tachykinins	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8866376	Reelin signalling pathway	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-446205	Synthesis of GDP-mannose	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-2161541	Abacavir metabolism	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-8866423	VLDL biosynthesis	1.00000000000363	3.62870327690321e-12	5	0	0	185	10293
R-HSA-72689	Formation of a pool of free 40S subunits	1.00000000000415	4.15010566191957e-12	105	0	0	185	10293
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-71288	Creatine metabolism	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-1059683	Interleukin-6 signaling	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-193048	Androgen biosynthesis	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-8875555	MET activates RAP1 and RAC1	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-3296469	Defects in cobalamin (B12) metabolism	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-5661231	Metallothioneins bind metals	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-73614	Pyrimidine salvage reactions	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-1839122	Signaling by activated point mutants of FGFR1	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-174414	Processive synthesis on the C-strand of the telomere	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-376172	DSCAM interactions	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-196780	Biotin transport and metabolism	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-5660526	Response to metal ions	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-2022923	Dermatan sulfate biosynthesis	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-2514853	Condensation of Prometaphase Chromosomes	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-71182	Phenylalanine and tyrosine catabolism	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-211999	CYP2E1 reactions	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-1980148	Signaling by NOTCH3	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-174490	Membrane binding and targetting of GAG proteins	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-2485179	Activation of the phototransduction cascade	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-1980150	Signaling by NOTCH4	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-5655291	Signaling by FGFR4 in disease	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-189451	Heme biosynthesis	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-5602498	MyD88 deficiency (TLR2/4)	1.00000000000427	4.27200969360563e-12	11	0	0	185	10293
R-HSA-2129379	Molecules associated with elastic fibres	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-418990	Adherens junctions interactions	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-1839124	FGFR1 mutant receptor activation	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-5654733	Negative regulation of FGFR4 signaling	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-180786	Extension of Telomeres	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-114452	Activation of BH3-only proteins	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-418360	Platelet calcium homeostasis	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-2022928	HS-GAG biosynthesis	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-73772	RNA Polymerase I Promoter Escape	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	1.00000000000501	5.01184596085691e-12	31	0	0	185	10293
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	1.00000000000509	5.09465265824392e-12	34	0	0	185	10293
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	1.00000000000509	5.09465265824392e-12	34	0	0	185	10293
R-HSA-159227	Transport of the SLBP independent Mature mRNA	1.00000000000509	5.09465265824392e-12	34	0	0	185	10293
R-HSA-3928663	EPHA-mediated growth cone collapse	1.00000000000509	5.09465265824392e-12	34	0	0	185	10293
R-HSA-5656169	Termination of translesion DNA synthesis	1.00000000000509	5.09465265824392e-12	34	0	0	185	10293
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	1.00000000000509	5.09465265824392e-12	34	0	0	185	10293
R-HSA-5654727	Negative regulation of FGFR2 signaling	1.00000000000509	5.09465265824392e-12	34	0	0	185	10293
R-HSA-73933	Resolution of Abasic Sites (AP sites)	1.00000000000517	5.1666665559877e-12	37	0	0	185	10293
R-HSA-73884	Base Excision Repair	1.00000000000517	5.1666665559877e-12	37	0	0	185	10293
R-HSA-5689896	Ovarian tumor domain proteases	1.00000000000517	5.1666665559877e-12	37	0	0	185	10293
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	1.00000000000517	5.1666665559877e-12	37	0	0	185	10293
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	1.00000000000533	5.32877906499146e-12	32	0	0	185	10293
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	1.00000000000533	5.32877906499146e-12	32	0	0	185	10293
R-HSA-73863	RNA Polymerase I Transcription Termination	1.00000000000533	5.32877906499146e-12	32	0	0	185	10293
R-HSA-196071	Metabolism of steroid hormones	1.00000000000533	5.32877906499146e-12	32	0	0	185	10293
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	1.00000000000533	5.32877906499146e-12	32	0	0	185	10293
R-HSA-1592389	Activation of Matrix Metalloproteinases	1.00000000000533	5.32877906499146e-12	32	0	0	185	10293
R-HSA-1181150	Signaling by NODAL	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-5654689	PI-3K cascade:FGFR1	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-3000170	Syndecan interactions	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-445144	Signal transduction by L1	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-500657	Presynaptic function of Kainate receptors	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-5423646	Aflatoxin activation and detoxification	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-5654688	SHC-mediated cascade:FGFR1	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-3000480	Scavenging by Class A Receptors	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-8849932	SALM protein interactions at the synapses	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-6807004	Negative regulation of MET activity	1.00000000000541	5.40931527563761e-12	21	0	0	185	10293
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	1.00000000000567	5.66749546484913e-12	124	0	0	185	10293
R-HSA-191273	Cholesterol biosynthesis	1.00000000000619	6.19332849323868e-12	24	0	0	185	10293
R-HSA-5602358	Diseases associated with the TLR signaling cascade	1.00000000000619	6.19332849323868e-12	24	0	0	185	10293
R-HSA-70895	Branched-chain amino acid catabolism	1.00000000000619	6.19332849323868e-12	24	0	0	185	10293
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	1.00000000000619	6.19332849323868e-12	24	0	0	185	10293
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	1.00000000000619	6.19332849323868e-12	24	0	0	185	10293
R-HSA-5260271	Diseases of Immune System	1.00000000000619	6.19332849323868e-12	24	0	0	185	10293
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	1.00000000000619	6.19332849323868e-12	24	0	0	185	10293
R-HSA-6794362	Protein-protein interactions at synapses	1.00000000000678	6.78042536877618e-12	73	0	0	185	10293
R-HSA-1980143	Signaling by NOTCH1	1.00000000000678	6.78042536877618e-12	73	0	0	185	10293
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	1.00000000000678	6.78042536877618e-12	73	0	0	185	10293
R-HSA-1237112	Methionine salvage pathway	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-6799990	Metal sequestration by antimicrobial proteins	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-68616	Assembly of the ORC complex at the origin of replication	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-111957	Cam-PDE 1 activation	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-388479	Vasopressin-like receptors	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-5336415	Uptake and function of diphtheria toxin	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-211916	Vitamins	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-5626978	TNFR1-mediated ceramide production	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-193993	Mineralocorticoid biosynthesis	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-166662	Lectin pathway of complement activation	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-187015	Activation of TRKA receptors	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-173623	Classical antibody-mediated complement activation	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-6793080	rRNA modification in the mitochondrion	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-176417	Phosphorylation of Emi1	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-428808	Na+-dependent glucose transporters	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-190370	FGFR1b ligand binding and activation	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-5674499	Negative feedback regulation of MAPK pathway	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-5690714	CD22 mediated BCR regulation	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-189483	Heme degradation	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-8849470	PTK6 Regulates Cell Cycle	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-6787639	GDP-fucose biosynthesis	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-5693548	Sensing of DNA Double Strand Breaks	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-390247	Beta-oxidation of very long chain fatty acids	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-8857538	PTK6 promotes HIF1A stabilization	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-2142700	Synthesis of Lipoxins (LX)	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-3000484	Scavenging by Class F Receptors	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-446199	Synthesis of Dolichyl-phosphate	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-1482798	Acyl chain remodeling of CL	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-3065679	SUMO is proteolytically processed	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-3323169	Defects in biotin (Btn) metabolism	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-193144	Estrogen biosynthesis	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-205025	NADE modulates death signalling	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-6806942	MET Receptor Activation	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-5676934	Protein repair	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-177135	Conjugation of benzoate with glycine	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-444257	RSK activation	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-500753	Pyrimidine biosynthesis	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-8851907	MET activates PI3K/AKT signaling	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	1.00000000000683	6.82991866022779e-12	6	0	0	185	10293
R-HSA-6783783	Interleukin-10 signaling	1.00000000000708	7.07877230734419e-12	49	0	0	185	10293
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.00000000000708	7.07877230734419e-12	49	0	0	185	10293
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000000751	7.5052054272673e-12	53	0	0	185	10293
R-HSA-6806667	Metabolism of fat-soluble vitamins	1.00000000000751	7.5052054272673e-12	53	0	0	185	10293
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000000751	7.5052054272673e-12	53	0	0	185	10293
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-3295583	TRP channels	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-5673000	RAF activation	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-182971	EGFR downregulation	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-977068	Termination of O-glycan biosynthesis	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-5654708	Downstream signaling of activated FGFR3	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-425410	Metal ion SLC transporters	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-5654700	FRS-mediated FGFR2 signaling	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-1538133	G0 and Early G1	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-1614635	Sulfur amino acid metabolism	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-203927	MicroRNA (miRNA) biogenesis	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-211981	Xenobiotics	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-389661	Glyoxylate metabolism and glycine degradation	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-933542	TRAF6 mediated NF-kB activation	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	1.00000000000807	8.06835407803118e-12	25	0	0	185	10293
R-HSA-2682334	EPH-Ephrin signaling	1.00000000000834	8.33714581184807e-12	95	0	0	185	10293
R-HSA-2408557	Selenocysteine synthesis	1.00000000000834	8.33714581184807e-12	95	0	0	185	10293
R-HSA-168273	Influenza Viral RNA Transcription and Replication	1.0000000000086	8.59897692444307e-12	137	0	0	185	10293
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	1.00000000000888	8.88180661609024e-12	43	0	0	185	10293
R-HSA-168325	Viral Messenger RNA Synthesis	1.00000000000888	8.88180661609024e-12	43	0	0	185	10293
R-HSA-5655253	Signaling by FGFR2 in disease	1.00000000000888	8.88180661609024e-12	43	0	0	185	10293
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	1.00000000000888	8.88180661609024e-12	43	0	0	185	10293
R-HSA-375280	Amine ligand-binding receptors	1.00000000000888	8.88180661609024e-12	43	0	0	185	10293
R-HSA-6784531	tRNA processing in the nucleus	1.00000000000947	9.47331847967597e-12	60	0	0	185	10293
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-3232118	SUMOylation of transcription factors	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-622312	Inflammasomes	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-5625900	RHO GTPases activate CIT	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-5655862	Translesion synthesis by POLK	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-139853	Elevation of cytosolic Ca2+ levels	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-2142845	Hyaluronan metabolism	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-435354	Zinc transporters	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-432142	Platelet sensitization by LDL	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-5656121	Translesion synthesis by POLI	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-1482922	Acyl chain remodelling of PI	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-156711	Polo-like kinase mediated events	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-189445	Metabolism of porphyrins	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-2033519	Activated point mutants of FGFR2	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-5627117	RHO GTPases Activate ROCKs	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-3296482	Defects in vitamin and cofactor metabolism	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-193639	p75NTR signals via NF-kB	1.00000000000979	9.78799980450907e-12	17	0	0	185	10293
R-HSA-75953	RNA Polymerase II Transcription Initiation	1.00000000001062	1.06243465066543e-11	47	0	0	185	10293
R-HSA-167161	HIV Transcription Initiation	1.00000000001062	1.06243465066543e-11	47	0	0	185	10293
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	1.00000000001062	1.06243465066543e-11	47	0	0	185	10293
R-HSA-73776	RNA Polymerase II Promoter Escape	1.00000000001062	1.06243465066543e-11	47	0	0	185	10293
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	1.00000000001062	1.06243465066543e-11	47	0	0	185	10293
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	1.00000000001062	1.06243465066543e-11	47	0	0	185	10293
R-HSA-72649	Translation initiation complex formation	1.00000000001079	1.07872971781094e-11	62	0	0	185	10293
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.00000000001079	1.07872971781094e-11	62	0	0	185	10293
R-HSA-4615885	SUMOylation of DNA replication proteins	1.0000000000108	1.0803576405178e-11	46	0	0	185	10293
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	1.00000000001117	1.1168307060433e-11	93	0	0	185	10293
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1.0000000000115	1.14952976058589e-11	63	0	0	185	10293
R-HSA-1226099	Signaling by FGFR in disease	1.0000000000115	1.14952976058589e-11	63	0	0	185	10293
R-HSA-5669034	TNFs bind their physiological receptors	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-157858	Gap junction trafficking and regulation	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-5654696	Downstream signaling of activated FGFR2	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-381042	PERK regulates gene expression	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-2871809	FCERI mediated Ca+2 mobilization	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-420029	Tight junction interactions	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-420092	Glucagon-type ligand receptors	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-5683826	Surfactant metabolism	1.00000000001154	1.15407657444998e-11	30	0	0	185	10293
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	1.00000000001205	1.20511167261015e-11	50	0	0	185	10293
R-HSA-167169	HIV Transcription Elongation	1.00000000001205	1.20511167261015e-11	50	0	0	185	10293
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	1.00000000001205	1.20511167261015e-11	50	0	0	185	10293
R-HSA-73893	DNA Damage Bypass	1.00000000001205	1.20511167261015e-11	50	0	0	185	10293
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	1.00000000001211	1.21082912999678e-11	104	0	0	185	10293
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-205043	NRIF signals cell death from the nucleus	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-3371568	Attenuation phase	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-391903	Eicosanoid ligand-binding receptors	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-156581	Methylation	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-69183	Processive synthesis on the lagging strand	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-5682910	LGI-ADAM interactions	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-69298	Association of licensing factors with the pre-replicative complex	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-5358508	Mismatch Repair	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-111447	Activation of BAD and translocation to mitochondria	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-3322077	Glycogen synthesis	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-975577	N-Glycan antennae elongation	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-211935	Fatty acids	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	1.0000000000122	1.22045641629698e-11	15	0	0	185	10293
R-HSA-72737	Cap-dependent Translation Initiation	1.00000000001232	1.23181267087076e-11	125	0	0	185	10293
R-HSA-72613	Eukaryotic Translation Initiation	1.00000000001232	1.23181267087076e-11	125	0	0	185	10293
R-HSA-168255	Influenza Life Cycle	1.0000000000131	1.31009946472795e-11	146	0	0	185	10293
R-HSA-5696400	Dual Incision in GG-NER	1.00000000001333	1.33288059982322e-11	41	0	0	185	10293
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	1.00000000001333	1.33288059982322e-11	41	0	0	185	10293
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	1.00000000001333	1.33288059982322e-11	41	0	0	185	10293
R-HSA-74158	RNA Polymerase III Transcription	1.00000000001333	1.33288059982322e-11	41	0	0	185	10293
R-HSA-5654743	Signaling by FGFR4	1.00000000001333	1.33288059982322e-11	41	0	0	185	10293
R-HSA-2408522	Selenoamino acid metabolism	1.00000000001372	1.37150223381793e-11	121	0	0	185	10293
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	1.00000000001376	1.37562526503073e-11	115	0	0	185	10293
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-5619102	SLC transporter disorders	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-171319	Telomere Extension By Telomerase	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-199920	CREB phosphorylation	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-447038	NrCAM interactions	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-447043	Neurofascin interactions	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-164843	2-LTR circle formation	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-433692	Proton-coupled monocarboxylate transport	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-6814848	Glycerophospholipid catabolism	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-448706	Interleukin-1 processing	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-5652084	Fructose metabolism	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-174577	Activation of C3 and C5	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-429593	Inositol transporters	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-174362	Transport and synthesis of PAPS	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-190371	FGFR3b ligand binding and activation	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-196791	Vitamin D (calciferol) metabolism	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-420597	Nectin/Necl  trans heterodimerization	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000001383	1.38334677340161e-11	7	0	0	185	10293
R-HSA-397795	G-protein beta:gamma signalling	1.00000000001452	1.45224251621251e-11	51	0	0	185	10293
R-HSA-1461973	Defensins	1.00000000001452	1.45224251621251e-11	51	0	0	185	10293
R-HSA-6799198	Complex I biogenesis	1.00000000001452	1.45224251621251e-11	51	0	0	185	10293
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	1.00000000001491	1.49135023937614e-11	68	0	0	185	10293
R-HSA-216083	Integrin cell surface interactions	1.00000000001491	1.49135023937614e-11	68	0	0	185	10293
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.00000000001491	1.49135023937614e-11	68	0	0	185	10293
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	1.00000000001503	1.50275747010899e-11	58	0	0	185	10293
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	1.00000000001503	1.50275747010899e-11	58	0	0	185	10293
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	1.00000000001503	1.50275747010899e-11	58	0	0	185	10293
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	1.00000000001503	1.50275747010899e-11	58	0	0	185	10293
R-HSA-2644603	Signaling by NOTCH1 in Cancer	1.00000000001503	1.50275747010899e-11	58	0	0	185	10293
R-HSA-156590	Glutathione conjugation	1.00000000001563	1.56274156159213e-11	38	0	0	185	10293
R-HSA-76009	Platelet Aggregation (Plug Formation)	1.00000000001563	1.56274156159213e-11	38	0	0	185	10293
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000001563	1.56274156159213e-11	38	0	0	185	10293
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000001563	1.56274156159213e-11	38	0	0	185	10293
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1.00000000001563	1.56274156159213e-11	38	0	0	185	10293
R-HSA-5655302	Signaling by FGFR1 in disease	1.00000000001563	1.56274156159213e-11	38	0	0	185	10293
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1.00000000001638	1.63774125819664e-11	99	0	0	185	10293
R-HSA-2990846	SUMOylation	1.000000000017	1.70020735206771e-11	110	0	0	185	10293
R-HSA-72306	tRNA processing	1.0000000000176	1.75957051373466e-11	109	0	0	185	10293
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-112409	RAF-independent MAPK1/3 activation	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-400508	Incretin synthesis, secretion, and inactivation	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-5627123	RHO GTPases activate PAKs	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-5654693	FRS-mediated FGFR1 signaling	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-5654695	PI-3K cascade:FGFR2	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-5654699	SHC-mediated cascade:FGFR2	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-73980	RNA Polymerase III Transcription Termination	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-8863678	Neurodegenerative Diseases	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-379726	Mitochondrial tRNA aminoacylation	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-428930	Thromboxane signalling through TP receptor	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-8855121	VLDL interactions	1.00000000001766	1.76639223105035e-11	23	0	0	185	10293
R-HSA-927802	Nonsense-Mediated Decay (NMD)	1.00000000001787	1.78714369630546e-11	120	0	0	185	10293
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	1.00000000001787	1.78714369630546e-11	120	0	0	185	10293
R-HSA-6783310	Fanconi Anemia Pathway	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-165159	mTOR signalling	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-69231	Cyclin D associated events in G1	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-5696394	DNA Damage Recognition in GG-NER	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-69236	G1 Phase	1.00000000001903	1.90342052434475e-11	39	0	0	185	10293
R-HSA-373752	Netrin-1 signaling	1.00000000001916	1.91622560293437e-11	42	0	0	185	10293
R-HSA-1566948	Elastic fibre formation	1.00000000001916	1.91622560293437e-11	42	0	0	185	10293
R-HSA-3928662	EPHB-mediated forward signaling	1.00000000001916	1.91622560293437e-11	42	0	0	185	10293
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000001916	1.91622560293437e-11	42	0	0	185	10293
R-HSA-1461957	Beta defensins	1.00000000001916	1.91622560293437e-11	42	0	0	185	10293
R-HSA-168253	Host Interactions with Influenza Factors	1.00000000001916	1.91622560293437e-11	42	0	0	185	10293
R-HSA-421270	Cell-cell junction organization	1.00000000002003	2.00279902853985e-11	61	0	0	185	10293
R-HSA-72702	Ribosomal scanning and start codon recognition	1.00000000002003	2.00279902853985e-11	61	0	0	185	10293
R-HSA-2980736	Peptide hormone metabolism	1.00000000002032	2.03170434996988e-11	91	0	0	185	10293
R-HSA-1839126	FGFR2 mutant receptor activation	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-5654726	Negative regulation of FGFR1 signaling	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-180746	Nuclear import of Rev protein	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-202433	Generation of second messenger molecules	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-392518	Signal amplification	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-180910	Vpr-mediated nuclear import of PICs	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-389356	CD28 co-stimulation	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-1222556	ROS, RNS production in phagocytes	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-1980145	Signaling by NOTCH2	1.0000000000204	2.03954681126424e-11	33	0	0	185	10293
R-HSA-72312	rRNA processing	1.00000000002105	2.10480732845757e-11	201	0	0	185	10293
R-HSA-416476	G alpha (q) signalling events	1.00000000002186	2.18569344819079e-11	192	0	0	185	10293
R-HSA-168254	Influenza Infection	1.00000000002258	2.25773013371705e-11	157	0	0	185	10293
R-HSA-1474165	Reproduction	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-210991	Basigin interactions	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-73848	Pyrimidine metabolism	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-379716	Cytosolic tRNA aminoacylation	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-1187000	Fertilization	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-3238698	WNT ligand biogenesis and trafficking	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-2029485	Role of phospholipids in phagocytosis	1.00000000002316	2.31575582859938e-11	26	0	0	185	10293
R-HSA-1433617	Regulation of signaling by NODAL	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-417957	P2Y receptors	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-211958	Miscellaneous substrates	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-1236977	Endosomal/Vacuolar pathway	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-2160916	Hyaluronan uptake and degradation	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-166786	Creation of C4 and C2 activators	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-73621	Pyrimidine catabolism	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-451306	Ionotropic activity of Kainate Receptors	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-8866427	VLDLR internalisation and degradation	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-4641265	Repression of WNT target genes	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-1839130	Signaling by activated point mutants of FGFR3	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-190373	FGFR1c ligand binding and activation	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-209822	Glycoprotein hormones	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-879518	Transport of organic anions	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-390666	Serotonin receptors	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-8851680	Butyrophilin (BTN) family interactions	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-71384	Ethanol oxidation	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-3656237	Defective EXT2 causes exostoses 2	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-3371511	HSF1 activation	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-71064	Lysine catabolism	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-844456	The NLRP3 inflammasome	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-203615	eNOS activation	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-5578768	Physiological factors	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-2033514	FGFR3 mutant receptor activation	1.00000000002336	2.33591880468151e-11	12	0	0	185	10293
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1.00000000002393	2.39332826549614e-11	117	0	0	185	10293
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1.00000000002393	2.39332826549614e-11	117	0	0	185	10293
R-HSA-72766	Translation	1.00000000002459	2.45908775288565e-11	162	0	0	185	10293
R-HSA-6805567	Keratinization	1.0000000000246	2.46039072332767e-11	214	0	0	185	10293
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	1.00000000002466	2.46603806228042e-11	44	0	0	185	10293
R-HSA-5668914	Diseases of metabolism	1.00000000002466	2.46603806228042e-11	44	0	0	185	10293
R-HSA-975634	Retinoid metabolism and transport	1.00000000002466	2.46603806228042e-11	44	0	0	185	10293
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	1.00000000002466	2.46603806228042e-11	44	0	0	185	10293
R-HSA-8868773	rRNA processing in the nucleus and cytosol	1.00000000002566	2.56565862392983e-11	191	0	0	185	10293
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	1.00000000002642	2.64211835540782e-11	48	0	0	185	10293
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	1.00000000002642	2.64211835540782e-11	48	0	0	185	10293
R-HSA-380108	Chemokine receptors bind chemokines	1.00000000002642	2.64211835540782e-11	48	0	0	185	10293
R-HSA-4570464	SUMOylation of RNA binding proteins	1.00000000002642	2.64211835540782e-11	48	0	0	185	10293
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	1.00000000002642	2.64211835540782e-11	48	0	0	185	10293
R-HSA-73762	RNA Polymerase I Transcription Initiation	1.00000000002642	2.64211835540782e-11	48	0	0	185	10293
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	1.00000000002642	2.64211835540782e-11	48	0	0	185	10293
R-HSA-400253	Circadian Clock	1.00000000002859	2.85921838329491e-11	71	0	0	185	10293
R-HSA-6809371	Formation of the cornified envelope	1.00000000002859	2.85921838329491e-11	71	0	0	185	10293
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1.00000000003347	3.34687444256887e-11	179	0	0	185	10293
